Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20080065225 A1
Publication typeApplication
Application numberUS 11/890,307
Publication dateMar 13, 2008
Filing dateAug 3, 2007
Priority dateFeb 18, 2005
Also published asCA2598391A1, CA2598391C, CA2769658A1, CA2769658C, EP1850803A2, EP1850803A4, EP1850803B1, EP2818187A2, EP2818187A3, US8956418, US20150051455, WO2006089069A2, WO2006089069A3, WO2006089069A8
Publication number11890307, 890307, US 2008/0065225 A1, US 2008/065225 A1, US 20080065225 A1, US 20080065225A1, US 2008065225 A1, US 2008065225A1, US-A1-20080065225, US-A1-2008065225, US2008/0065225A1, US2008/065225A1, US20080065225 A1, US20080065225A1, US2008065225 A1, US2008065225A1
InventorsRay Wasielewski, Richard Komistek, Mohamed Mahfouz
Original AssigneeWasielewski Ray C, Komistek Richard D, Mahfouz Mohamed R
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Smart joint implant sensors
US 20080065225 A1
Abstract
A prosthesis for implantation into a mammalian body, the device comprising: (a) a prosthesis for implantation into a mammalian body that includes a sensor array comprising a plurality of sensors mounted to the prosthesis; and (b) an electronics structure for receiving signals from the sensor array and wirelessly transmitting representative signals to a remote receiver, where the plurality of sensors are operative to sense pressure, applied to the prosthesis by another object, in at least two axes generally perpendicular to one another.
Images(17)
Previous page
Next page
Claims(35)
1. A prosthesis for implantation into a mammalian body, the device comprising:
a prosthesis for implantation into a mammalian body that includes a sensor array comprising a plurality of sensors mounted to the prosthesis; and
an electronics structure for receiving signals from the sensor array and wirelessly transmitting representative signals to a remote receiver;
wherein the plurality of sensors are operative to sense pressure, applied to the prosthesis by another object, in at least two axes generally perpendicular to one another.
2. The prosthesis of claim 1, wherein the electronics structure includes a timing circuit configured to automatically activate the sensor array and to automatically deactivate the sensor array.
3. The prosthesis of claim 1, wherein the plurality of sensors include at least one of resistive microcantilevers, piezoelectric microcantilevers, and microcapacitor sensors.
4. The prosthesis of claim 1, wherein the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis.
5. The prosthesis of claim 1, wherein at least one of the sensor array and the electronics structure is powered using at least one of electromagnetic induction, radio frequency induction, and battery power.
6. The prosthesis of claim 1, wherein the electronics structure includes a microcontroller and a transmitter.
7. The prosthesis of claim 1, wherein the electronics structure includes an application specific integrated circuit, which includes a filter for filtering out low frequency noise.
8. The prosthesis of claim 1, wherein the electronics structure includes an application specific integrated circuit, which includes an amplifier for amplifying signals from the sensor array.
9. The prosthesis of claim 1, wherein the electronics structure includes an application specific integrated circuit, which includes a multiplexer for multiplexing signals from the sensor array.
10. The prosthesis of claim 1, wherein the electronics structure includes an application specific integrated circuit, which includes an analog-to-digital converter for converting analog signals from the sensor array to digital signals.
11. The prosthesis of claim 1, wherein the electronics structure includes an application specific integrated circuit, which includes a processor for processing signals from the sensor array.
12. The prosthesis of claim 1, wherein at least one of the plurality of sensors is operative to sense temperature.
13. The prosthesis of claim 1, wherein the prosthesis includes a microchannel and a micropump in communication with the microchannel to pump mammalian bodily fluid bathing the joint through the microchannel, where an interior of the microchannel is in communication with at least one of the plurality of sensors.
14. A prosthesis for implantation into a mammalian body, the device comprising:
a prosthesis for implantation into a mammalian body that includes a sensor array comprising a plurality of sensors mounted to the prosthesis; and
an electronics structure for receiving signals from the sensor array and wirelessly transmitting representative signals to a remote receiver;
wherein at least one of the plurality of sensors is in fluid communication with fluids bathing the prosthesis.
15. The prosthesis of claim 14, wherein the sensor array includes sensors detecting at least one of a predetermined component, a predetermined contaminant, and a predetermined property.
16. The prosthesis of claim 14, wherein the electronics structure includes a timing circuit configured to automatically activate the sensor array and to automatically deactivate the sensor array.
17. The prosthesis of claim 14, wherein the plurality of sensors include at least one of resistive microcantilevers, piezoelectric microcantilevers, and microcapacitor sensors.
18. The prosthesis of claim 14, wherein the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis.
19. The prosthesis of claim 14, wherein at least one of the plurality of sensors of the sensor array is operative to sense at least one of: leukocyte concentration, neutrophil concentration, bacterial deoxyribonucleic acid concentration, antibody concentration, glucose concentration, excitatory amino acids concentration, lactate dehydrogenase concentration, hyaluronic acid concentration, uric acid concentration, calcium pyrophosphate concentration, beta-glucuronidase concentration, nerve growth factor concentration, insulin-like growth factor concentration, Caeruloplasmin concentration, and oxidase concentration.
20. The prosthesis of claim 14, wherein at least one of the sensor array and the electronics structure is powered using at least one of electromagnetic induction, radio frequency induction, and battery power.
21. The prosthesis of claim 14, wherein the electronics structure includes a microcontroller and a transmitter.
22. The prosthesis of claim 14, wherein the electronics structure includes an application specific integrated circuit, which includes a filter for filtering out low frequency noise.
23. The prosthesis of claim 14, wherein the electronics structure includes an application specific integrated circuit, which includes an amplifier for amplifying signals from the sensor array.
24. The prosthesis of claim 14, wherein the electronics structure includes an application specific integrated circuit, which includes a multiplexer for multiplexing signals from the sensor array.
25. The prosthesis of claim 14, wherein the electronics structure includes an application specific integrated circuit, which includes an analog-to-digital converter for converting analog signals from the sensor array to digital signals.
26. The prosthesis of claim 14, wherein the electronics structure includes an application specific integrated circuit, which includes a processor for processing signals from the sensor array.
27. The prosthesis of claim 14, wherein the prosthesis includes a microchannel and a micropump in communication with the microchannel to pump mammalian bodily fluid bathing the joint through the microchannel, where an interior of the microchannel is in communication with at least one of the plurality of sensors.
27. (canceled)
28. A method of monitoring a prosthetic implant and its host mammalian body, the method comprising the steps of:
implanting a sensor array into the mammalian body, the sensor array mounted to a prosthesis also implanted into the mammalian body;
sensing pressure applied to the prosthesis in at least two axes generally perpendicular to one another;
generating signals responsive to the sensed pressure applied to the prosthesis by another object; and
wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the pressure.
29-43. (canceled)
44. A method of monitoring a prosthetic implant and its host mammalian body, the method comprising the steps of:
implanting a sensor array into the mammalian body, the sensor array mounted to a prosthesis also implanted into the mammalian body, where at least one sensor of the sensor array is in fluid communication with fluids bathing the prosthesis;
sensing a condition of at least one of a predetermined component, a predetermined contaminant, and a predetermined property using the sensor array;
generating signals responsive to the sensed condition; and
wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the condition.
45-59. (canceled)
60. A method of fabricating a prosthesis, the method comprising:
fabricating a prosthesis with a fluid conduit adapted to be in fluid communication with a mammalian bodily fluid bathing the prosthetic joint; and
orienting a plurality of sensors into fluid communication with the interior of the fluid conduit, where the sensors are operative to detect at least one of a predetermined component, a predetermined contaminant, and a predetermined property.
61. A sensor array comprising:
a first capacitive sensor comprising conductive plates separated by a dielectric material, the capacitive plates of the first capacitive sensor lying along a first X-Y and operative to detect pressure along the X axis;
a second capacitive sensor comprising conductive plates separated from one another, the capacitive plates of the second capacitive sensor lying along the first X-Y plane and operative to detect pressure along the Y axis; and
a third capacitive sensor comprising conductive plates separated from one another, the capacitive plates of the third capacitive sensor lying along the first X-Y plane and operative to detect pressure along a Z plane orthogonal to the first X-Y plane.
62. A prosthetic implant comprising:
a prosthetic sensor array mounted to a prosthesis, the sensor array including at least one sensor in fluid communication with a fluid surrounding the prosthesis subsequent to implanting the prosthesis into a mammalian body, where the at least one sensor is operative to detect at least one of the following properties: viscosity of the synovial fluid; pH of the synovial fluid; cell count within the synovial fluid; protein within the synovial fluid; phospholipids within the synovial fluid; hyaluronic acid within the synovial fluid; leukocytes within the synovial fluid; neutrophils within the synovial fluid; bacterial deoxyribonucleic acid within the synovial fluid; antibodies within the synovial fluid; glucose concentration within the synovial fluid; lactate dehydrogenase (LDH) within the synovial fluid; uric acid crystals within the synovial fluid; MMP-9 antigens (gelatinase-B) within the synovial fluid; nerve growth factor within the synovial fluid; excitatory amino acids (EAA) glutamate and aspartate within the synovial fluid; insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 within the synovial fluid; oxidase activity within the synovial fluid; polyamine oxidases within the synovial fluid; caeruloplasmin (Cp) concentration within the synovial fluid; beta-glucuronidase content within the synovial fluid; S100A8/A9 within the synovial fluid; C reactive protein within the synovial fluid; rheumatoid factor within the synovial fluid; C3 and C4 within the synovial fluid; metal particulate within the synovial fluid; polyethylene particulate within the synovial fluid; bone particulate within the synovial fluid; cement particulate within the synovial fluid; osteolytic enzymes within the synovial fluid; genetic markers within the synovial fluid; antibody markers within the synovial fluid; temperature of the synovial fluid; specific gravity of the synovial fluid; and white cells (and differential cell type) within the synovial fluid; and
a transmitter in electrical communication with the at least one sensor of the sensor array and operative to transmit data to a remote receive indicative of at least one sensed property.
Description
    CROSS REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation that claims priority under 35 U.S.C. §120 of Patent Cooperation Treaty Application Serial No. PCT/US2006/005545 filed on Feb. 18, 2006, entitled “SMART JOINT IMPLANT INSERTS,” which claimed priority under 35 U.S.C. §119 to U.S. Provisional Patent Application Ser. No. 60/654,650, filed Feb. 18, 2005, entitled “SURGICAL SMART INSERTS,” the disclosure of which is hereby incorporated by reference.
  • RELATED ART
  • [0002]
    1. Field of the Invention
  • [0003]
    The present invention is directed to sensors for utilization in the health care industry and, more specifically, to miniature sensors for use in prosthetic implants and prosthetic trials.
  • [0004]
    2. Prospective of Related Art
  • [0005]
    Failure of total joint arthroplasty (TJA) can be a rapid or insidious process. In cases of rapid failure, the diagnosis is often obvious, but unfortunately often too late to avoid surgical revision. Fortunately, most joint replacements simulate the joints of the body and slowly degrade over time for more subtle mechanical and biologic reasons. If a reliable detection method or system was operative to detect insidious or subtle failure and infection, these conditions can be mitigated or even reversed.
  • [0006]
    TJA failure etiologies can be divided generally into mechanical and biologic causes. The mechanical causes are generally wear of the articular surfaces and loosening of the prosthetic components. Abnormal loading conditions that are present immediately post-operatively or that worsen over time can directly affect the wear process. By the time these processes are apparent using conventional detection methods (e.g., linear wear on radiographs, implant-bone junction radiolucencies, and osteolytic bone defects from excessive particulate wear debris) it is often too late for optimum implant survival to be achieved. By the time lucencies are seen between the various components and the bone, loosing has occurred and failure is eminent. Only early detection of these impending failures can allow for the possibility for simple or more conservative interventions to correct joint mechanical anomalies before becoming irreversible.
  • [0007]
    Biologic failure of the TJA can be attributable to inflammation or infection. Aseptic loosening can be seen as progressive radiolucencies on radiographs, but once again, too late for effective intervention. However, subtle changes in the synovial fluid might signal an insidious failure, thereby allowing non-operative intervention as opposed to complete revision surgery.
  • [0008]
    The markers for different failure modes of prosthetic implants are known. The following listing of references is indicative of the current knowledge regarding these markers. For example, increased pressure associated with the synovial fluid may be indicative of infection (see http://www.kcom.edu/faculty/chamberlain/Website/lectures/tritzid/septarthritis.htm (septic arthritis)). In addition, is has been observed that synovial fluid having a low pH may be indicative of infection (see http://www.kcom.edu/faculty/chamberlain/Website/lectures/tritzid/septarthritis.htm (septic arthritis)) (see also Tulamo R. M. et al., Equine Vet. J., 1989 September; 21(5):325-31 (infectious arthritis, horse for pH below 6.9). The following references also acknowledge other markers indicative of infections: (1A) leukocyte (WBC) count is increased (see Trampuz A. et al., Am. J. Med., 2004 Oct. 15; 117(8):556-62 (infected TKA); (1B) leukocyte (WBC) count is greater than or equal to 2500 per milliliter (see Mason J. B. et al., J. Arthroplasty, 2003 December; 18(8):1038-43 (revision TKA)); (2A) neutrophil (polymorphonuclear cells (PMNCs)) percentage is increased (see Trampuz A. et al., Am. J. Med., 2004 Oct. 15; 117(8):556-62 (infected TKA)); (2B) neutrophil (polymorphonuclear cells (PMNCs)) percentage is greater than or equal to 60% (see Mason J. B. et al., J. Arthroplasty, 2003 December; 18(8):1038-43 (revision TKA)); (3) presence of bacterial deoxyribonucleic acid (detected by polymerase chain reaction) (see Mariani B. D. et al., Clin. Orthop., 1996 October; (331):11-22).
  • [0009]
    Additional markers associated with synovial fluid that are indicative of infection include: (4) presence of antibodies (see http://www.kcom.edu/faculty/chamberlain/Website/lectures/tritzid/septarthritis.htm (septic arthritis)); (5A) low glucose concentration (must compare to blood glucose level) (see Tulamo R. M. et al., Equine Vet. J., 1989 September; 21(5):325-31 (infectious arthritis, horse)); (5B) low glucose concentration of less than 40 mg/dL (see http://my.webmd.com/hw/arthritis/hw231503.asp); (5C) low glucose concentration less than 0.6% (see http://www.kcom.edu/faculty/chamberlain/Website/lectures/tritzid/septarthritis.htm (septic arthritis); (6A) elevated protein level (see Tulamo R. M. et al., Equine Vet. J., 1989 September; 21(5):325-31 (infectious arthritis, horse)); (6B) elevated protein level greater than or equal to 3 g/dL (see http://my.webmd.com/hw/arthritis/hw231503.asp); (7) higher concentration of excitatory amino acids (EAA) glutamate and aspartate (also related to arthritis) (see McNeamey T. et al., J. Rheumatol., 2000 March; 27(3):739-45); (8a) elevated level of lactate dehydrogenase (when blood levels of LDH are normal) (see Tulamo R. M. et al., Equine Vet. J., 1989 September; 21(5):325-31. (infectious arthritis, horse); (8b) elevated level of lactate dehydrogenase (when blood levels of LDH are normal) greater than 333 IU/L (see http://my.webmd.com/hw/ arthritis/hw231503.asp); and (9) white cell gene expression (see Deirmengian C., Clin. Orthop. Related Res., November 2005; 440:38-40).
  • [0010]
    Those of ordinary skill are familiar with other markers such as, without limitation, lower viscosity of the synovial fluid (see Mazzucco D. et al., J. Orthop. Res., 2002 November; 20(6): 1157-63) and lower hyaluronic acid (HA) content (see Mazzucco D. et al., Biomaterials, 2004 August; 25(18):4433-45) signifying a failing or failed TKA. Other markers, such as, without limitation, the presence of uric acid crystals (monosodium urate monohydrate crystals) (see Ryckman C. et al., Arthritis Rheum., 2003 August; 48(8):2310-20), the presence of calcium pyrophosphate crystals indicates pseudogout (see http://my.webmd.com/hw/arthritis/hw231503.asp), elevated leukocyte count (see Canoso J. J. et al., Arthritis Rheum., 1979 December; 22(12):1361-4), elevated level of lactate dehydrogenase (when blood levels of LDH are normal) greater than 333 IU/L (see http://my.webmd.com/hw/arthritis/hw231503.asp), elevated MMP-9 (gelatinase-B) antigen levels (see Hsieh M. S. et al., J. Cell. Biochem., 2003 Jul. 1; 89(4):791-0), and high concentrations of S100A8/A9 (see Ryckman C. et al., Arthritis Rheum., 2003 August; 48(8):2310-20) may be indicative of gout.
  • [0011]
    Further markers of synovial fluid indicative of arthritic patients include, without limitation, (1) lower concentration, elasticity and viscosity (see Fukuda K., Clin. Calcium, 2004 July; 14(7):103-7. (elasticity and viscosity); Mazzucco D. et al., J. Orthop. Res., 2002 November; 20(6): 1157-63; Moskowitz R. W. et al., Am. J. Orthop., 2004 February; 33(2 Suppl):5-9; Adams M. E. et al., Drug Saf., 2000 August; 23(2):115-30 (Hyaluronan smaller in size (OA)); Adams M. E. et al., Drug Saf., 2000 August; 23(2): 115-30 (Lower concentration of hyaluronan)); (2) higher cell count (see Fawthrop F. et al., Br. J. Rheumatol, 1985 February; 24(1):61-9; Dieppe P. A. et al., Arthritis Rheum., 1988 July; 31(7):882-90); (3) the presence of C reactive protein (CRP) (see Rowe I. F. et al., Ann. Rheum. Dis., 1987 October; 46(10):721-6); (4) higher concentration of amino acids (see McNearney T. et al., J. Rheumatol., 2000 March; 27(3):739-45); (5) higher concentration of excitatory amino acids (EAA) glutamate and aspartate (McNeamey T. et al., J. Rheumatol., 2000 March; 27(3):739-45); (6) presence of rheumatoid factor (RA) (see Sari L. et al., Rev. Med. Chil., 1993 December; 121(12):1374-81) (7) elevated IgE rheumatoid factor activity (RA) (see Gruber et al., Clin. Exp. Immunol., 1988 February; 71(2):289-94); (8) higher beta-glucuronidase content (OA) (see Fawthrop F. et al., Br. J. Rheumatol., 1985 February; 24(1):61-9); (9) increased nerve growth factor (NGF) concentration (see Halliday D. A. et al., Neurochem. Res., 1998 June; 23(6):919-22); (10) higher levels of insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 (in inflammatory joints) (see Kanety H. et al., J. Rheumatol., 1996 May; 23(5):815-8); (11) higher Caeruloplasmin (Cp) concentration (RA and psoriatic arthritis) (see Dixon J. S. et al., Rheumatol Int., 1988; 8(1):11-4); (12) elevated oxidase activity (RA and psoriatic arthritis) (see Dixon J. S. et al., Rheumatol Int., 1988; 8(1): 11-4); and, (13) presence of polyamine oxidases (PAO) (RA) (see Ferrante A. et al., Clin. Exp. Immunol., 1990 June; 80(3):373-5).
  • [0012]
    Some methods do exist for the detection of failing implants, but often are too late to positively impact treatment. Synovial fluid can be withdrawn from the joint at yearly follow-up, but with an increased risk of causing infection. Labs can be taken each year, but these labs show systemic effects that often occur only after extensive joint damage, where the systemic effects may not necessarily be specific to the joint.
  • [0013]
    Thus, there is a need in the art for a non-invasive system and associated method to test for these markers in-vivo with the ability to transmit the test/detection data externally to an electronic data storage device during physician follow-ups signals to the patient that the conditions are abnormal, such as a prosthesis vibrating or otherwise objectively signaling to the patient.
  • INTRODUCTION TO THE INVENTION
  • [0014]
    The present invention is directed to sensors for utilization in the health care industry and, more specifically, to miniature sensors for use in prosthetic implants and prosthetic trials. The present invention encompasses intelligent implants incorporating sensors operative to measure different mechanical and biologic markers for prosthetic failure. Additionally, the sensors of the present invention are operative to monitor the distributed forces at such joints as the femorotibial and patellofemoral joints, providing a comparison with both post-op and the established norms. A properly balanced knee is neither too loose, nor too tight, and will be reflected from the output from the sensors in the medial and lateral compartments transmitting signals indicative of appropriate joint pressure.
  • [0015]
    The invention may include a series of microsensing elements (“array”) and a micropump fabricated using semiconductor or MEMS (microelectromechanical systems) fabrication technology. The sensors may be arranged in an array of sensing elements that are externally powered by either electromagnetic induction or radio frequency (RF) induction or internally powered using a battery or other power storage device. Data representative of that generated by the sensors is remotely transmitted using RF technology or other alternate technology known to those of ordinary skill or arising hereafter, thereby obviating any reliance on continuous wire-based communication from the sensors to the eventual output device. Pressure sensing elements, temperature sensing elements, and chemical sensing elements may be included in each sensor array in order to provide a more complete picture for an attending physician during, and subsequent to, surgery. For example, the aforementioned elements or other elements are operative to generate data indicative of the presence of infection and the pressure exerted upon one or more predetermined surfaces of a prosthetic implant.
  • [0016]
    There are numerous possible applications for the present invention. For starters, the present invention is applicable to prosthetic surgeries involving joint replacement. It is to be understood that the present invention is not limited to joint replacement surgeries, and may be easily modified to impart the desired functionality for any operational endeavor or any external fixation device such as a smart brace. The exemplary disclosure as recited herein is also applicable to prosthetic trial components, thereby giving the surgeon substantially real-time information about pressure distributions prior to fitting the eventual implanted prosthesis. As a breakthrough technology, the present invention allows unparalleled synergy between previously unrelated fields such as biology and microelectronics to enable monitoring of conditions not previously monitorable without the associated risk of infection or other complications.
  • [0017]
    In exemplary form, the present invention includes a sensor array, associated with a prosthetic implant, that is operative to detect at least one of: viscosity of the synovial fluid; pH of the synovial fluid; cell count within the synovial fluid; protein within the synovial fluid; phospholipids within the synovial fluid; hyaluronic acid within the synovial fluid; leukocytes within the synovial fluid; neutrophils within the synovial fluid; bacterial deoxyribonucleic acid within the synovial fluid; antibodies within the synovial fluid; glucose concentration within the synovial fluid; lactate dehydrogenase (LDH) within the synovial fluid; uric acid crystals within the synovial fluid; MMP-9 antigens (gelatinase-B) within the synovial fluid; nerve growth factor within the synovial fluid; excitatory amino acids (EAA) glutamate and aspartate within the synovial fluid; insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 within the synovial fluid; oxidase activity within the synovial fluid; polyamine oxidases within the synovial fluid; caeruloplasmin (Cp) concentration within the synovial fluid; beta-glucuronidase content within the synovial fluid; S100A8/A9 within the synovial fluid; C reactive protein within the synovial fluid; rheumatoid factor within the synovial fluid; C3 and C4 within the synovial fluid; metal particulate within the synovial fluid; polyethylene particulate within the synovial fluid; bone particulate within the synovial fluid; cement particulate within the synovial fluid; osteolytic enzymes within the synovial fluid; genetic markers within the synovial fluid; antibody markers within the synovial fluid; temperature of the synovial fluid; specific gravity of the synovial fluid; and white cells (and differential cell type) within the synovial fluid. The sensed condition is routed through a wireless transmitter and broadcast to a remote terminal. In a further exemplary embodiment, the sensor array and transmitter are integrated into a prosthetic device and subsequent to surgery, housed completely within the mammalian body. The data attributable to the sensor array is received by a remote terminal, which in exemplary form comprises a personal data assistant. A warning sign of early infection detection could be a configured to correspond to a predetermined sound, a predetermined frequency, or other signal.
  • [0018]
    The present invention is applicable outside of the summary examples recited above and reference is had to the remainder of the written description to more fully understand the scope and spirit of the present invention.
  • [0019]
    It is a first aspect of the present invention to provide a prosthesis for implantation into a mammalian body, the device comprising: (a) a prosthesis for implantation into a mammalian body that includes a sensor array comprising a plurality of sensors mounted to the prosthesis; and (b) an electronics structure for receiving signals from the sensor array and wirelessly transmitting representative signals to a remote receiver.
  • [0020]
    In a more detailed embodiment of the first aspect, the sensor array includes sensors detecting at least one of a predetermined component, a predetermined contaminant, and a predetermined property. In yet another more detailed embodiment, the plurality of sensors include at least one of an encapsulated sensor and a sensor in fluid communication with mammalian bodily fluids bathing the prosthesis. In a further detailed embodiment, the electronics structure includes a timing circuit configured to automatically activate the sensor array and to automatically deactivate the sensor array. In still a further detailed embodiment, the plurality of sensors include at least one of resistive microcantilevers, piezoelectric microcantilevers, and microcapacitor sensors. In a more detailed embodiment, the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis. In a more detailed embodiment, the prosthesis includes a knee replacement femoral prosthesis and the sensor array is embedded within the knee replacement femoral prosthesis. In another more detailed embodiment, the prosthesis includes a knee replacement tibial prosthesis and the sensor array is embedded within the knee replacement tibial prosthesis. In yet another more detailed embodiment, the prosthesis includes a knee replacement tibial tray prosthesis and the sensor array is embedded within the knee replacement tibial tray prosthesis. In still another more detailed embodiment, the prosthesis includes a hip replacement femoral prosthesis and the sensor array is embedded within the hip replacement femoral prosthesis.
  • [0021]
    In yet another more detailed embodiment of the first aspect, the prosthesis includes a hip replacement acetabular cup prosthesis and the sensor array is embedded within the hip replacement acetabular cup prosthesis. In still another more detailed embodiment, the prosthesis includes a hip replacement acetabular cup insert prosthesis and the sensor array is embedded within the hip replacement acetabular cup insert prosthesis. In a further detailed embodiment, at least one of the plurality of sensors of the sensor array is operative to sense at least one of: leukocyte concentration, neutrophil concentration, bacterial deoxyribonucleic acid concentration, antibody concentration, glucose concentration, excitatory amino acids concentration, lactate dehydrogenase concentration, hyaluronic acid concentration, uric acid concentration, calcium pyrophosphate concentration, beta-glucuronidase concentration, nerve growth factor concentration, insulin-like growth factor concentration, Caeruloplasmin concentration, and oxidase concentration. In still a further detailed embodiment, at least one of the sensor array and the electronics structure is powered using at least one of electromagnetic induction, radio frequency induction, and battery power. In a more detailed embodiment, the electronics structure includes a microcontroller and a transmitter. In a more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a filter for filtering out low frequency noise. In another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes an amplifier for amplifying signals from the sensor array. In yet another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a multiplexer for multiplexing signals from the sensor array.
  • [0022]
    In yet another more detailed embodiment of the first aspect, the electronics structure includes an application specific integrated circuit, which includes an analog-to-digital converter for converting analog signals from the sensor array to digital signals. In still another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a processor for processing signals from the sensor array. In a further detailed embodiment, the sensors of the sensor array are operative to sense at least one of pressure and temperature. In still a further detailed embodiment, the prosthesis includes a microchannel and a micropump in communication with the microchannel to pump mammalian bodily fluid bathing the joint through the microchannel, where an interior of the microchannel is in communication with at least one of the plurality of sensors. In a more detailed embodiment, the wireless transmission of representative signals is accomplished using a radio frequency transmitter. In a more detailed embodiment, the plurality of sensors are operative to sense pressure changes in three axes of movement.
  • [0023]
    It is a second aspect of the present invention to provide a method of monitoring a prosthetic implant and its host mammalian body, the method comprising the steps of: (a) implanting a sensor array into the mammalian body, the sensor array accompanying a prosthesis also implanted into the mammalian body; (b) sensing a condition of at least one of a predetermined component, a predetermined contaminant, and a predetermined property using the sensor array; (c) generating signals responsive to the sensed condition; (d) wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the condition; and (e) processing the transmitted signals by the remote receiver to generate data representative of the sensed condition.
  • [0024]
    In a more detailed embodiment of the first aspect, the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis. In yet another more detailed embodiment, the invention also includes filtering out low frequency noise from the generated signals prior to the wirelessly transmitting step. In a further detailed embodiment, the invention also includes amplifying the generated signals prior to the wirelessly transmitting step. In still a further detailed embodiment, the invention also includes multiplexing the generated signals prior to the wirelessly transmitting step. In a more detailed embodiment, the invention also includes converting the generated signals from analog to digital prior to the wirelessly transmitting step. In a more detailed embodiment, the invention also includes processing the generated signals prior to the wirelessly transmitting step. In another more detailed embodiment, the step of sensing the condition includes sensing at least one of pressure and temperature. In yet another more detailed embodiment, the step of sensing the condition includes utilizing at least one of a microcantilever and a microcapacitor. In still another more detailed embodiment, the step of sensing the condition includes sensing for markers of infection.
  • [0025]
    In yet another more detailed embodiment of the first aspect, the step of sensing the condition includes encapsulated sensors responsive to pressure changes. In still another more detailed embodiment, the step of sensing the condition includes sensors in fluid communication with bodily fluids bathing the prosthesis. In a further detailed embodiment, the invention also includes displaying visual representations of the data generated by or during the processing step, and responding to the displayed visual representations to take appropriate corrective action where applicable. In still a further detailed embodiment, the step of sensing the condition includes the use of encapsulated sensors responsive to pressure changes. In a more detailed embodiment, the step of sensing the condition includes sensing at least one of: leukocyte concentration, neutrophil concentration, bacterial deoxyribonucleic acid concentration, antibody concentration, glucose concentration, excitatory amino acids concentration, lactate dehydrogenase concentration, hyaluronic acid concentration, uric acid concentration, calcium pyrophosphate concentration, beta-glucuronidase concentration, nerve growth factor concentration, insulin-like growth factor concentration, Caeruloplasmin concentration, and oxidase concentration
  • [0026]
    It is a third aspect of the present invention to provide a method of detecting infection within mammalian body, the method comprising the steps of: (a) implanting a sensor array into the mammalian body, the sensor array accompanying a prosthesis also implanted into the mammalian body; (b) sensing for a marker representative of infection; (c) generating signals from the sensor array when the marker representative of infection is sensed; (d) wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the marker; and (e) processing the transmitted signals by the remote receiver to generate data representative of the sensed marker.
  • [0027]
    It is a fourth aspect of the present invention to provide a method of detecting premature failure of a prosthetic implant in a host mammalian body, the method comprising the steps of: (a) implanting a sensor array into the mammalian body, the sensor array accompanying a prosthesis also implanted into the mammalian body; (b) sensing conditions comprising at least one of pressure and constituents of mammalian bodily fluid bathing the prosthesis; (c) generating signals responsive to the sensed conditions; (d) wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the conditions; and (e) processing the transmitted signals by the remote receiver to generate data representative of the sensed condition.
  • [0028]
    It is a fifth aspect of the present invention to provide a method of fabricating a prosthesis, the method comprising: (a) associating a prosthetic component with a fluid conduit adapted to be in fluid communication with a mammalian bodily fluid bathing the prosthetic joint; and (b) orienting a plurality of sensors into fluid communication with the interior of the fluid conduit, where the sensors are operative to detect at least one of a predetermined component, a predetermined contaminant, and a predetermined property.
  • [0029]
    It is a sixth aspect of the present invention to provide a method of fabricating a sensor array, the method comprising: (a) mounting a plurality of microcantilevers sensors onto a substrate in a predetermined distribution; and (b) encapsulating the microcantilever sensors.
  • [0030]
    It is a seventh aspect of the present invention to provide a method of fabricating a sensor array, the method comprising: (a) fabricating a plurality of capacitive sensors a plurality of microcantilevers sensors onto a substrate in a predetermined distribution; and (b) encapsulating the microcantilever sensors.
  • [0031]
    It is an eighth seventh aspect of the present invention to provide an external brace for supplementing the support structure of a mammalian body, the device comprising: (a) an external brace for mounting to the exterior of a mammalian body, the brace including a sensor array mounted thereto; and (b) an electronics structure for receiving data from the sensor array and wirelessly transmitting representative data to a remote receiver.
  • [0032]
    It is a ninth aspect of the present invention to provide a sensor array comprising: (a) a first capacitive sensor comprising conductive plates separated by a dielectric material, the capacitive plates of the first capacitive sensor lying along a first X-Y and operative to detect pressure along the X axis; (b) a second capacitive sensor comprising conductive plates separated from one another, the capacitive plates of the second capacitive sensor lying along the first X-Y plane and operative to detect pressure along the Y axis; and (c) a third capacitive sensor comprising conductive plates separated from one another, the capacitive plates of the third capacitive sensor lying along the first X-Y plane and operative to detect pressure along a Z plane orthogonal to the first X-Y plane.
  • [0033]
    It is a tenth aspect of the present invention to provide a prosthetic trial implant having a microcantilevered sensor array integral to the prosthetic trial implant and operatively coupled to a transmitter to communicate sensed data to a remote transmitter, where the sensed data is indicative of current conditions of a fluid in communication with at least one sensor of the sensor array.
  • [0034]
    It is an eleventh aspect of the present invention to provide a prosthesis having a microcantilevered sensor array integral to the prosthetic permanent implant and operatively coupled to a transmitter to communicate sensed data to a remote transmitter, the sensor array and transmitter including inductively powered and operative to detect at least one of temperature, pressure, and pH of a fluid in communication with at least one sensor of the sensor array.
  • [0035]
    It is a twelfth aspect of the present invention to provide a prosthetic implant including a microelectromechanical controller coupled to a microcantilevered sensor array integral to the prosthetic implant and operative to sense environmental conditions relative to the prosthetic implant to detect wear of the prosthetic implant more than three months subsequent to a prosthetic implant surgery and provide data to a remote data receiving device operative to allow a physician to determine whether adjustments and/or surgical repair is warranted.
  • [0036]
    It is a thirteenth aspect of the present invention to provide a prosthetic implant comprising: (a) a prosthetic support structure operative to be mounted to a preexisting support structure of a mammalian body; (b) a sensor array having a plurality of sensors, where at least one of the sensors is operative to detect at least one of viscosity of the synovial fluid; pH of the synovial fluid; cell count within the synovial fluid; protein within the synovial fluid; phospholipids within the synovial fluid; hyaluronic acid within the synovial fluid; leukocytes within the synovial fluid; neutrophils within the synovial fluid; bacterial deoxyribonucleic acid within the synovial fluid; antibodies within the synovial fluid; glucose concentration within the synovial fluid; lactate dehydrogenase (LDH) within the synovial fluid; uric acid crystals within the synovial fluid; MMP-9 antigens (gelatinase-B) within the synovial fluid; nerve growth factor within the synovial fluid; excitatory amino acids (EAA) glutamate and aspartate within the synovial fluid; insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 within the synovial fluid; oxidase activity within the synovial fluid; polyamine oxidases within the synovial fluid; caeruloplasmin (Cp) concentration within the synovial fluid; beta-glucuronidase content within the synovial fluid; S100A8/A9 within the synovial fluid; C reactive protein within the synovial fluid; rheumatoid factor within the synovial fluid; C3 and C4 within the synovial fluid; metal particulate within the synovial fluid; polyethylene particulate within the synovial fluid; bone particulate within the synovial fluid; cement particulate within the synovial fluid; osteolytic enzymes within the synovial fluid; genetic markers within the synovial fluid; antibody markers within the synovial fluid; temperature of the synovial fluid; specific gravity of the synovial fluid; and white cells (and differential cell type) within the synovial fluid; and (c) a transmitter in electrical communication with at least one sensor of the sensor array and operative to transmit data to a remote receive indicative of at least one of viscosity of the synovial fluid; pH of the synovial fluid; cell count within the synovial fluid; protein within the synovial fluid; phospholipids within the synovial fluid; hyaluronic acid within the synovial fluid; leukocytes within the synovial fluid; neutrophils within the synovial fluid; bacterial deoxyribonucleic acid within the synovial fluid; antibodies within the synovial fluid; glucose concentration within the synovial fluid; lactate dehydrogenase (LDH) within the synovial fluid; uric acid crystals within the synovial fluid; MMP-9 antigens (gelatinase-B) within the synovial fluid; nerve growth factor within the synovial fluid; excitatory amino acids (EAA) glutamate and aspartate within the synovial fluid; insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 within the synovial fluid; oxidase activity within the synovial fluid; polyamine oxidases within the synovial fluid; caeruloplasmin (Cp) concentration within the synovial fluid; beta-glucuronidase content within the synovial fluid; S100A8/A9 within the synovial fluid; C reactive protein within the synovial fluid; rheumatoid factor within the synovial fluid; C3 and C4 within the synovial fluid; metal particulate within the synovial fluid; polyethylene particulate within the synovial fluid; bone particulate within the synovial fluid; cement particulate within the synovial fluid; osteolytic enzymes within the synovial fluid; genetic markers within the synovial fluid; antibody markers within the synovial fluid; temperature of the synovial fluid; specific gravity of the synovial fluid; and white cells (and differential cell type) within the synovial fluid.
  • [0037]
    It is a fourteenth aspect of the present invention to provide a prosthesis for implantation into a mammalian body, the device comprising: (a) a prosthesis for implantation into a mammalian body that includes a sensor array comprising a plurality of sensors mounted to the prosthesis; and (b) an electronics structure for receiving signals from the sensor array and wirelessly transmitting representative signals to a remote receiver where the plurality of sensors are operative to sense pressure, applied to the prosthesis by another object, in at least two axes generally perpendicular to one another.
  • [0038]
    In a more detailed embodiment of the fourteenth aspect, the electronics structure includes a timing circuit configured to automatically activate the sensor array and to automatically deactivate the sensor array. In yet another more detailed embodiment, the plurality of sensors include at least one of resistive microcantilevers, piezoelectric microcantilevers, and microcapacitor sensors. In a further detailed embodiment, the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis. In still a further detailed embodiment, at least one of the sensor array and the electronics structure is powered using at least one of electromagnetic induction, radio frequency induction, and battery power. In a more detailed embodiment, the electronics structure includes a microcontroller and a transmitter. In a more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a filter for filtering out low frequency noise. In another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes an amplifier for amplifying signals from the sensor array. In yet another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a multiplexer for multiplexing signals from the sensor array. In still another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes an analog-to-digital converter for converting analog signals from the sensor array to digital signals.
  • [0039]
    In yet another more detailed embodiment of the fourteenth aspect, the electronics structure includes an application specific integrated circuit, which includes a processor for processing signals from the sensor array. In still another more detailed embodiment, at least one of the plurality of sensors is operative to sense temperature. In a further detailed embodiment, the prosthesis includes a microchannel and a micropump in communication with the microchannel to pump mammalian bodily fluid bathing the joint through the microchannel, where an interior of the microchannel is in communication with at least one of the plurality of sensors. In still a further detailed embodiment,. In a more detailed embodiment,. In a more detailed embodiment,. In another more detailed embodiment,. In yet another more detailed embodiment,.
  • [0040]
    It is a fifteenth aspect of the present invention to provide a prosthesis for implantation into a mammalian body, the device comprising: (a) a prosthesis for implantation into a mammalian body that includes a sensor array comprising a plurality of sensors mounted to the prosthesis; and (b) an electronics structure for receiving signals from the sensor array and wirelessly transmitting representative signals to a remote receiver, where at least one of the plurality of sensors is in fluid communication with fluids bathing the prosthesis.
  • [0041]
    In a more detailed embodiment of the fifteenth aspect, the sensor array includes sensors detecting at least one of a predetermined component, a predetermined contaminant, and a predetermined property. In yet another more detailed embodiment, the electronics structure includes a timing circuit configured to automatically activate the sensor array and to automatically deactivate the sensor array. In a further detailed embodiment, the plurality of sensors include at least one of resistive microcantilevers, piezoelectric microcantilevers, and microcapacitor sensors. In still a further detailed embodiment, the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis. In a more detailed embodiment, at least one of the plurality of sensors of the sensor array is operative to sense at least one of: leukocyte concentration, neutrophil concentration, bacterial deoxyribonucleic acid concentration, antibody concentration, glucose concentration, excitatory amino acids concentration, lactate dehydrogenase concentration, hyaluronic acid concentration, uric acid concentration, calcium pyrophosphate concentration, beta-glucuronidase concentration, nerve growth factor concentration, insulin-like growth factor concentration, Caeruloplasmin concentration, and oxidase concentration.
  • [0042]
    In yet another more detailed embodiment of the fifteenth aspect, at least one of the sensor array and the electronics structure is powered using at least one of electromagnetic induction, radio frequency induction, and battery power. In still another more detailed embodiment, the electronics structure includes a microcontroller and a transmitter. In a further detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a filter for filtering out low frequency noise. In still a further detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes an amplifier for amplifying signals from the sensor array. In a more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a multiplexer for multiplexing signals from the sensor array. In a more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes an analog-to-digital converter for converting analog signals from the sensor array to digital signals. In another more detailed embodiment, the electronics structure includes an application specific integrated circuit, which includes a processor for processing signals from the sensor array. In yet another more detailed embodiment, the prosthesis includes a microchannel and a micropump in communication with the microchannel to pump mammalian bodily fluid bathing the joint through the microchannel, where an interior of the microchannel is in communication with at least one of the plurality of sensors. In yet a further more detailed embodiment, the wireless transmission of representative signals is accomplished using a radio frequency transmitter.
  • [0043]
    It is a sixteenth aspect of the present invention to provide a method of monitoring a prosthetic implant and its host mammalian body, the method comprising the steps of: (a) implanting a sensor array into the mammalian body, the sensor array mounted to a prosthesis also implanted into the mammalian body; (b) sensing pressure applied to the prosthesis in at least two axes generally perpendicular to one another; (c) generating signals responsive to the sensed pressure applied to the prosthesis by another object; and (d) wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the pressure.
  • [0044]
    In a more detailed embodiment of the sixteenth aspect, the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis. In yet another more detailed embodiment, the method also includes filtering out low frequency noise from the generated signals prior to the wirelessly transmitting step. In a further detailed embodiment, the method also includes amplifying the generated signals prior to the wirelessly transmitting step. In still a further detailed embodiment, the method also includes multiplexing the generated signals prior to the wirelessly transmitting step. In a more detailed embodiment, the method further includes converting the generated signals from analog to digital prior to the wirelessly transmitting step. In a more detailed embodiment, the method further includes processing the generated signals prior to the wirelessly transmitting step. In another more detailed embodiment, the step of sensing the condition includes sensing at least one of pressure and temperature. In yet another more detailed embodiment, the step of sensing the condition includes utilizing at least one of a microcantilever and a microcapacitor. In still another more detailed embodiment, the step of sensing the condition includes sensing for markers of infection.
  • [0045]
    In yet another more detailed embodiment of the sixteenth aspect, the step of sensing the condition includes encapsulated sensors responsive to pressure changes. In still another more detailed embodiment, the step of sensing the condition includes sensors in fluid communication with bodily fluids bathing the prosthesis. In a further detailed embodiment, the method further includes displaying visual representations of the data generated by or during the processing step, and responding to the displayed visual representations to take appropriate corrective action where applicable. In still a further detailed embodiment, the step of sensing the condition includes the use of encapsulated sensors responsive to pressure changes. In a more detailed embodiment, the step of sensing the condition includes sensing at least one of: leukocyte concentration, neutrophil concentration, bacterial deoxyribonucleic acid concentration, antibody concentration, glucose concentration, excitatory amino acids concentration, lactate dehydrogenase concentration, hyaluronic acid concentration, uric acid concentration, calcium pyrophosphate concentration, beta-glucuronidase concentration, nerve growth factor concentration, insulin-like growth factor concentration, Caeruloplasmin concentration, and oxidase concentration. In a more detailed embodiment, the method further includes processing the transmitted signals by the remote receiver to generate data representative of the sensed pressure.
  • [0046]
    It is a seventeenth aspect of the present invention to provide a method of monitoring a prosthetic implant and its host mammalian body, the method comprising the steps of: (a) implanting a sensor array into the mammalian body, the sensor array mounted to a prosthesis also implanted into the mammalian body, where at least one sensor of the sensor array is in fluid communication with fluids bathing the prosthesis; (b) sensing a condition of at least one of a predetermined component, a predetermined contaminant, and a predetermined property using the sensor array; (c) generating signals responsive to the sensed condition; and (d) wirelessly transmitting signals to a remote receiver outside of the mammalian body, the transmitted signals being representative of signals generated by the sensor array in response to sensing the condition.
  • [0047]
    In a more detailed embodiment of the seventeenth aspect, the prosthesis includes at least one of a knee replacement femoral prosthesis, a knee replacement tibial prosthesis, a knee replacement tibial tray prosthesis, a hip replacement femoral prosthesis, a hip replacement acetabular cup prosthesis, a hip replacement acetabular cup insert prosthesis, a trial knee replacement femoral prosthesis, a trial knee replacement tibial prosthesis, a trial knee replacement tibial tray prosthesis, a trial hip replacement femoral prosthesis, a trial hip replacement acetabular cup prosthesis, and a trail hip replacement acetabular cup insert prosthesis. In yet another more detailed embodiment, the method further comprises filtering out low frequency noise from the generated signals prior to the wirelessly transmitting step. In a further detailed embodiment, the method further comprises amplifying the generated signals prior to the wirelessly transmitting step. In still a further detailed embodiment, the method further comprises multiplexing the generated signals prior to the wirelessly transmitting step. In a more detailed embodiment, the method further comprises converting the generated signals from analog to digital prior to the wirelessly transmitting step. In a more detailed embodiment, the method further comprises processing the generated signals prior to the wirelessly transmitting step. In another more detailed embodiment, the step of sensing the condition includes sensing at least one of pressure and temperature. In yet another more detailed embodiment, the step of sensing the condition includes utilizing at least one of a microcantilever and a microcapacitor. In still another more detailed embodiment, the step of sensing the condition includes sensing for markers of infection.
  • [0048]
    In yet another more detailed embodiment of the seventeenth aspect, the step of sensing the condition includes encapsulated sensors responsive to pressure changes. In still another more detailed embodiment, the step of sensing the condition includes sensors in fluid communication with bodily fluids bathing the prosthesis. In a further detailed embodiment, the method further comprises displaying visual representations of the data generated by or during the processing step, and responding to the displayed visual representations to take appropriate corrective action where applicable. In still a further detailed embodiment, the step of sensing the condition includes the use of encapsulated sensors responsive to pressure changes. In a more detailed embodiment, the step of sensing the condition includes sensing at least one of: leukocyte concentration, neutrophil concentration, bacterial deoxyribonucleic acid concentration, antibody concentration, glucose concentration, excitatory amino acids concentration, lactate dehydrogenase concentration, hyaluronic acid concentration, uric acid concentration, calcium pyrophosphate concentration, beta-glucuronidase concentration, nerve growth factor concentration, insulin-like growth factor concentration, Caeruloplasmin concentration, and oxidase concentration. In a more detailed embodiment, the method further comprises processing the transmitted signals by the remote receiver to generate data representative of the sensed condition.
  • [0049]
    It is an eighteenth aspect of the present invention to provide a method of fabricating a prosthesis, the method comprising: (a) fabricating a prosthesis with a fluid conduit adapted to be in fluid communication with a mammalian bodily fluid bathing the prosthetic joint; and (b) orienting a plurality of sensors into fluid communication with the interior of the fluid conduit, where the sensors are operative to detect at least one of a predetermined component, a predetermined contaminant, and a predetermined property.
  • [0050]
    It is a nineteenth aspect of the present invention to provide a sensor array comprising: (a) a first capacitive sensor comprising conductive plates separated by a dielectric material, the capacitive plates of the first capacitive sensor lying along a first X-Y and operative to detect pressure along the X axis; (b) a second capacitive sensor comprising conductive plates separated from one another, the capacitive plates of the second capacitive sensor lying along the first X-Y plane and operative to detect pressure along the Y axis; and (c) a third capacitive sensor comprising conductive plates separated from one another, the capacitive plates of the third capacitive sensor lying along the first X-Y plane and operative to detect pressure along a Z plane orthogonal to the first X-Y plane.
  • [0051]
    It is a twentieth aspect of the present invention to provide a prosthetic implant comprising: (a) a prosthetic sensor array mounted to a prosthesis, the sensor array including at least one sensor in fluid communication with a fluid surrounding the prosthesis subsequent to implanting the prosthesis into a mammalian body, where the at least one sensor is operative to detect at least one of the following properties: viscosity of the synovial fluid; pH of the synovial fluid; cell count within the synovial fluid; protein within the synovial fluid; phospholipids within the synovial fluid; hyaluronic acid within the synovial fluid; leukocytes within the synovial fluid; neutrophils within the synovial fluid; bacterial deoxyribonucleic acid within the synovial fluid; antibodies within the synovial fluid; glucose concentration within the synovial fluid; lactate dehydrogenase (LDH) within the synovial fluid; uric acid crystals within the synovial fluid; MMP-9 antigens (gelatinase-B) within the synovial fluid; nerve growth factor within the synovial fluid; excitatory amino acids (EAA) glutamate and aspartate within the synovial fluid; insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 within the synovial fluid; oxidase activity within the synovial fluid; polyamine oxidases within the synovial fluid; caeruloplasmin (Cp) concentration within the synovial fluid; beta-glucuronidase content within the synovial fluid; S100A8/A9 within the synovial fluid; C reactive protein within the synovial fluid; rheumatoid factor within the synovial fluid; C3 and C4 within the synovial fluid; metal particulate within the synovial fluid; polyethylene particulate within the synovial fluid; bone particulate within the synovial fluid; cement particulate within the synovial fluid; osteolytic enzymes within the synovial fluid; genetic markers within the synovial fluid; antibody markers within the synovial fluid; temperature of the synovial fluid; specific gravity of the synovial fluid; and white cells (and differential cell type) within the synovial fluid; and (b) a transmitter in electrical communication with the at least one sensor of the sensor array and operative to transmit data to a remote receive indicative of at least one sensed property.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0052]
    FIG. 1 is a frontal view of an exemplary tibial tray in accordance with the present invention;
  • [0053]
    FIG. 2 is a left side view of the exemplary tibial tray of FIG. 1;
  • [0054]
    FIG. 3 is a frontal view of an exemplary tibial tray insert in accordance with the present invention;
  • [0055]
    FIG. 4 is a left side view of the exemplary tibial tray insert of FIG. 3;
  • [0056]
    FIG. 5 is a top view of an exemplary femoral prosthesis in accordance with the present invention;
  • [0057]
    FIG. 6 is a left side view of the exemplary femoral prosthesis of FIG. 5;
  • [0058]
    FIG. 7 is an exemplary schematic representation of the electronic functions carried out by the exemplary control electronics of the present invention;
  • [0059]
    FIG. 8 is a wiring diagram of the electronics in communication with the sensors of the first exemplary embodiment of the present invention;
  • [0060]
    FIG. 9 is a wiring diagram of the amplifier and low pass filter in accordance with the first exemplary embodiment of the present invention;
  • [0061]
    FIG. 10 is a wiring diagram of the feedback display in accordance with the first exemplary embodiment of the present invention;
  • [0062]
    FIG. 11 is a wiring diagram of the interface with the transmitter in accordance with the first exemplary embodiment of the present invention;
  • [0063]
    FIG. 12 is a wiring diagram of the microcontroller in accordance with the first exemplary embodiment of the present invention;
  • [0064]
    FIG. 13 is a wiring diagram of the power management hardware in accordance with the first exemplary embodiment of the present invention;
  • [0065]
    FIG. 14 is a wiring diagram of the switch in accordance with the first exemplary embodiment of the present invention;
  • [0066]
    FIG. 15 is a wiring diagram of the JTAG interface with an output device in accordance with the first exemplary embodiment of the present invention;
  • [0067]
    FIG. 16 is a wiring diagram of the ASK transmitter in accordance with the first exemplary embodiment of the present invention;
  • [0068]
    FIG. 17 is an exemplary orientational diagram representing a first exemplary capacitor structure incorporated into an exemplary sensor for use with the first exemplary embodiment of the present invention;
  • [0069]
    FIG. 18 is an exemplary orientational diagram representing a second exemplary capacitor structure incorporated into an exemplary sensor for use with the first exemplary embodiment of the present invention;
  • [0070]
    FIG. 19 is an exemplary orientational diagram representing a third exemplary capacitor structure incorporated into an exemplary sensor for use with the first exemplary embodiment of the present invention;
  • [0071]
    FIG. 20 is an exemplary orientational diagram representing load cell for use with the first exemplary embodiment of the present invention;
  • [0072]
    FIG. 21 is an exemplary process flow diagram for fabricating an exemplary sensor for use with the first exemplary embodiment of the present invention;
  • [0073]
    FIG. 22 is an elevated perspective view of an exemplary microcantilever sensor for use with the first exemplary embodiment of the present invention;
  • [0074]
    FIG. 23 is an overhead view of the exemplary microcantilever of FIG. 22 calling out the integrated Wheatstone bridge;
  • [0075]
    FIG. 24 is an overhead diagram of an exemplary cantilever with dimensions in
  • [0076]
    FIG. 25 is an exemplary schematic diagram showing the interaction between hardware components to sense conditions and generate data, manipulate the data, and transmit the data to a remote devices in accordance with the first exemplary embodiment of the present invention;
  • [0077]
    FIGS. 26-28 are graphical depictions from a visual display representing various degrees of a sensed condition, such as pressure or concentration of a chemical species.
  • [0078]
    FIG. 29 is an exemplary piezoresistive microcantilever sensor mounted within a microchannel for sensing components, contaminants, and properties for use with the first exemplary embodiment of the present invention;
  • [0079]
    FIG. 30 is an exemplary capacitive microcantilever sensor mounted within a microchannel for sensing components, contaminants, and properties for use with the first exemplary embodiment of the present invention;
  • [0080]
    FIG. 31 is an exemplary tibial tray housing a dual-layer structure for use with the exemplary capacitive or piezoresistive microcantilevers of the present invention;
  • [0081]
    FIG. 32 is an overhead, exposed view of the tibial tray of FIG. 31 showing the exemplary layout of the capacitive or piezoresistive microcantilevers of the present invention, as well as the micropumps feeding fluid into the microchannels and discharging fluid from the microchannels;
  • [0082]
    FIG. 33 is an exposed view of a micropump in accordance with the present invention showing how fluid flows through the pump as an electric potential is applied at the terminals; and
  • [0083]
    FIG. 34 is a schematic diagram showing the electrical connection between the sensors and control circuitry for use with the present invention.
  • DETAILED DESCRIPTION
  • [0084]
    The exemplary embodiments of the present invention are described and illustrated below to encompass miniature sensors for use in the healthcare industry, such as sensors for use with prosthetic implants and prosthetic trials. Of course, it will be apparent to those of ordinary skill in the art that the preferred embodiments discussed below are exemplary in nature and may be reconfigured without departing from the scope and spirit of the present invention. However, for clarity and precision, the exemplary embodiments as discussed below may include optional steps, methods, and features that one of ordinary skill should recognize as not being a requisite to fall within the scope of the present invention.
  • [0085]
    Referencing FIGS. 1-6, a first exemplary embodiment of the present invention includes a prosthetic knee joint for use with a total knee arthroplasty procedure. The knee joint comprises a tibial tray 12, a tray insert 14, and a femoral prosthesis 16. The interaction and assembly of simple tibial trays, tray inserts, and femoral prostheses are well known to those skilled in the art. Consistent with the interaction of these simple prosthetic components, the exemplary components 12, 14, 16 of the knee joint of the present invention integrate and function as a replacement knee joint without compromising the primary functionality of the joint itself.
  • [0086]
    Referring specifically to FIGS. 1 and 2, the tibial tray 12 includes a downwardly extending shaft 18 mounted to a horizontal platform 24. The vertical shaft 18 houses an encoding and modulation device (EMD) 28 in communication with a microtransmitter 22. A sensor array 20 is mounted to the horizontal platform 24 that is also in communication with the EMD 28. An antenna 26 is mounted to the horizontal platform 24 and in communication with the microtransmitter 22, which receives signals from the EMD 28 to be transmitted to a remote electronic receiver (not shown). The sensor array 20 is distributed over the relevant areas of the platform 24 to effectively map those areas of the platform 24 contacted by the tray insert 14. The sensor array 20 may also include sensors adapted to sense components, contaminants, and properties exhibited by bodily fluids that surround the joint 10 subsequent to implantation. Regardless of the sensors utilized and particular data generated, detection data is communicated to the EMD 28, which in turn communicates data to the microtransmitter 22 that wirelessly transmits data using the antenna 32 to a remote electronic receiver 91 (see FIG. 25). Exemplary remote electronic receivers 91 include, without limitation, microcontroller based electronics such as a wireless telephone, a wireless personal data assistant, a personal computer, whether or not the electronic component includes a visual display. In an exemplary scenario, the remote receiver digital processes the signal from the implanted transmitter to generate a 3D graph that displays the load distribution on the sensing surface, as well as composition profiles for predetermined components, contaminants, and properties (see FIGS. 26-28).
  • [0087]
    Referencing FIGS. 3 and 4, the tibial insert 14 includes an upper vertical post 30 extending from a base 34 opposite that of a lower vertical post 31 (in some tibial inserts the lower vertical post 31 may be absent). The upper vertical post 30 includes an antenna 32 in communication with a microtransmitter 40 housed within the base 34, as well as a sensor array 36 and an EMD 38 also mounted within the base 34. The base 34 is contoured to include a pair of articular surfaces 42 adapted to receive the condyles 50 of the femoral prosthesis 16 (see FIGS. 5 and 6). Some of the sensors of the array 36 are positioned underneath the articular surfaces 42 in a predetermined manner that operates to map the relevant areas of the articular surfaces 42 that will be contacted by the condyles 50 throughout the range of movement of the joint 10 to generate data representative of a pressure map across the articular surfaces 42. The sensor array 36 also may include sensors that detect certain components, contaminants, and properties relevant to the joint 10 (see [0076]-[0077], for example) and generate detection data representative of the component, contaminant, or property detected. The detection data generated by the sensors of the array 36, whether pressure related or otherwise, is communicated to the EMD 38, which in turn communicates data to the microtransmitter 40 that wirelessly transmits data using the antenna 32 to a remote electronic receiver 91 (see FIG. 25).
  • [0088]
    Referencing FIGS. 5 and 6, the femoral prosthesis 16 includes a pair of U-shaped condyles 50 having a sensor array 52 in communication with an EMD 54, a microtransmitter 56, and an antenna 58. Numerous sensors of the array 52 are mounted to the condyles 50 to detect pressures exerted against the condyles, whereas other sensors within the array 52 may be adapted to be in fluid communication with the bodily fluids surrounding the joint 10 subsequent to the femoral prosthesis 16 being implanted. Those sensors of the array 52 that are in fluid communication with the bodily fluids surrounding the joint are operative to detect certain components, contaminants, and properties relevant to the joint 10 (see [0076]-[0077], for example) and generate detection data representative of the component, contaminant, or property detected. All of the detection data generated by the sensors of the array 52, whether pressure related or otherwise, is communicated to the EMD 54. The EMD 54 manipulates this data prior to communicating it to the microtransmitter 56 that wirelessly transmits data using the antenna 58 to a remote electronic receiver 91.
  • [0089]
    Referring to FIGS. 7 and 8, the EMDs 28, 38, 54 of the exemplary embodiments comprise ultra low-power, Application Specific Integrated Circuit (ASIC) or System on Chip (SOC) that includes, as will be described in detail below, signal detection and amplification functionality, anti-alias filtering functionality, multiplexing functionality, analog to digital conversion functionality, data processing functionality and transmission functionality. The SOC is programmed in accordance with the flowchart of FIG. 7 and designed for battery powering, such as a coin cell battery. A schematic diagram of the SOC is shown in FIG. 8, with the aforementioned component functions discussed in more detail below.
  • [0090]
    Signal Conditioning and Amplification
  • [0091]
    Generally, the output signal of each sensor is very small. In this regard, it is important to include a circuit 70 that filters out low frequency noise and amplifies the desired signal with an instrumentation amplifier into the SOC. The gain of the amplifier is adjustable with one off-chip resistor.
  • [0092]
    Analog Multiplexer
  • [0093]
    In order to obtain information of each sensor, an analog multiplexer (MUX) 72 is utilized between a readout circuit 74 and the signal conditioning circuit 70 of the system. The MUX 72 acts as a switch controlled by signals sent to the decoder from the microcontroller (MCU) 76. In exemplary form, the MUX 72 uses five addressing signals to select one channel at a time from numerous (such as 30) channels sequentially. The ON-resistance among these numerous channels should be matched to increase the MUX 72 static accuracy. In order to work in a high-speed mode, the ON-resistance should be relatively small, which, in turn, may lead to large chip size. Those of ordinary skill will understand the implications when trading off between speed and die area.
  • [0094]
    Analog to digital Conversion (ADC)
  • [0095]
    An 8-bit SAR ADC 78 was implemented in the exemplary SOC. Although Successive Approximation Register (SAR) ADC is a more complex analog-to-digital converting technique than digital ramp ADC, the former is much faster and the sampling time does not necessarily depend on the input voltage. An important part of the ADC 78 is a high resolution comparator, which has the ability to distinguish the minimum triggering signal with common mode voltage changing from 100 mV to 2 V. Consequentially, the SOC includes 256 quantization levels with precision of 7.4 mV. It is also important to match the 256 current sources to maintain good Integrated Non-Linearity (INL) and Differential Non-Linearity (DNL).
  • [0096]
    Data Processing
  • [0097]
    A comma generator and polarity check 80 are included with the SOC to facilitate distinguishing received data with their corresponding channels, as well as to facilitate detection of transmission errors. In exemplary form, an 8 bit start comma is sent prior to the signals from the first channel, and an end comma is sent after the last channel (channel 30, for example) signal. Thus, the receiver can check the received data's polarity to ensure the validity.
  • [0098]
    Transmitter
  • [0099]
    The transmitter 82 uses Amplitude Shift Keying (ASK) modulation with a carrier frequency at 433.92 MHz. As a result of potential inconsistencies in the Wheatstone bridge circuit, a feedback circuit with an off sensor is included with the SOC to ensure that it is balanced at all times.
  • [0100]
    Referring to FIGS. 10-16, numerous exemplary wiring diagrams for various parts of the SOC and components of the remote receiver 91 are provided. For example, FIG. 10 is the wiring diagram for the display of the output signal for the remote receiver, while FIG. 11 is the wiring diagram of the interface switch to the transmitter of the SOC. FIG. 12 is the wiring diagram for the microcontroller, whereas FIG. 13 is the wiring diagram for the power supply circuit of the SOC. FIG. 14 is a wiring diagram to the switch of the output display for the remote receiver 91, while FIG. 15 is the interface circuit with the computer (acting as a remote receiver), and FIG. 16 is the wiring diagram for the ASK transmitter circuit of the SOC.
  • [0101]
    Referencing FIGS. 17-20, a first exemplary set of sensors (1), (2), (3) for use in the exemplary arrays 20, 36, 52 include interdigitated capacitor sensors fabricated from biocompatible materials. Pairs of electrodes are embedded in a polymer matrix to form capacitors that are responsive to deformation of the embedding material. More specifically, the capacitance of the capacitors changes as the spacing between the electrodes changes, which can be correlated to an exerted pressure resulting from changes in the configuration of the capacitor electrodes.
  • [0102]
    Referring to FIG. 20, a load cell 106 includes a compilation of the exemplary interdigitated capacitor sensors. The load cell 106 includes a first sensor (1) comprised of two capacitor plates 90, 92 separated from one another. The load cell 106 also includes two second sensors (2) comprised of a two-layer differential capacitor comprising two electrodes 94, 96 with a potential applied between them, an overlapping electrode 98 at a floating potential, and a fourth electrode 100 underneath the floating electrode serving as a testing potential. The load cell 106 also includes three third sensors (3) comprised of opposing capacitor plates with numerous fingers 102, 104.
  • [0103]
    Each of the sensors (1), (2), (3) is operative to measure a force from differing directions. A single first sensor (1) is operative to detect forces normal to the surface of the substrate. Dual second sensors (2) are arranged generally along the same plane, and also in the same plane as the first sensor (1), but are angled 90 degrees with respect to one another to detect shear in the plane orthogonal to the substrate. Finally, three third sensors (3) are also arranged in the same plane as the first and second sensors (1), (2), however, these sensors are angled 45 degrees with respect to one another and measure the in-plane strain. In sum, the load cell 106 provides an exemplary repeatable grouping of sensors in a single plane that are operative to detect exerted pressures in two dimensions of the plane, as well as in directions orthogonal to the plane to provide three dimensional mapping capabilities. An exemplary load cell 106 has dimension of 1 mm×1 mm, however, smaller dimensions are possible such as, without limitaion, 0.1 mm×0.1 mm. An exemplar array 20, 36, 52 includes many multiples of load cells 106, such as two to eight hundred load cells 106.
  • [0104]
    Referencing FIG. 21, fabrication of the first set of exemplary sensors includes utilization of MEMS fabrication techniques adapted from silicon-based microcontroller fabrication. In this exemplary embodiment, the first set of sensors may be either fabricated in an embedded state on the eventual prosthetic component, or may be fabricated remote from the eventual prosthetic component by as using a portable substrate structure such as medical-grade UHMW polyethylene, parylene films, or silicon wafers. Oxygen plasma reactive ion etching techniques may also be used as a surface pretreatment to enable the electrodes to adhere to certain substrate surfaces.
  • [0105]
    An initial procedure starts with obtaining a clean substrate surface at step 110, which in this exemplary process includes a silicon wafer, a polyethylene wafer, and a parylene film. The silicon wafer is cleaned using the piranha process, a 5:1 ratio of H2SO4 to H2O2 at 120C. The polyethylene wafer is cleaned using a liquinox liquid soap cleaning solution with soft scrub, followed by an acetone rinse, a methanol rinse, and an isopropanol rinse. The surface of the polyethylene samples is then activated by exposure to an oxygen plasma or a combination of oxygen/nitrogen plasma. This step served to nano-roughen the surface and increase the energy of the surface by breaking down some of the polymer chains on the surface. The parylene substrate is oxidized with a 1 micron SiO2 layer prior to applying 10 more microns of parylene.
  • [0106]
    After the substrates have been cleaned and prepared for photoresist deposition, step 112 comprises spin-coating each substrate with a Shipley S1818 photoresist at 3000 RPM for 30 seconds. Immediately subsequent to deposition of the photoresist, the substrates are soft-baked on a hot plate for 60 seconds at 90C. Subsequent to the soft-backing step, contact lithography is used in step 114 to pattern transfer a positive mask onto the exposed surface of the substrates.
  • [0107]
    A baking step 116 follows the lithography step 114, where each substrate is baked for 80 minutes at 90C in NH3 gas in an image reversal oven. During the baking step 116, NH3 gas diffuses into the exposed areas and neutralizes the byproducts of the photodecomposition process to render the exposed areas highly resistant to further change by exposure to light and insensitive to further developing.
  • [0108]
    Next, the substrates are subjected to a flood exposure step 118 for 60 seconds to render the areas adjacent to the neutralized areas soluble in the photoresist developer, thereby reversing the pattern originally exposed in the positive photoresist step 112. Each substrate is spray developed in a developer for 60 seconds, followed by a 30 second exposure to an oxygen plasma thereby ensuring that all of the photoresist is removed from the substrate in the developed areas, as shown by step 120.
  • [0109]
    Subsequently, a metal deposition step 122 includes evaporating 100 angstroms of titanium onto each substrate as an adhesion layer, followed by 1500 angstroms of gold comprising the bulk of the metal layer. In this exemplary process, the metal deposition step 122 covers the entire surface of the substrates, where the eventual structure is brought about by dissolving the photoresist in acetone or other photoresist solvent during the lift-off process, leaving metal only the desired areas. Each of the substrates is then cleaned in a polar solvent, such as methanol, resulting in the structure shown in step 124. Each subsequent layer of conductive material may be deposited by repeating the above recited process, interposing dielectric material between the conductive patterns. By way of example, and not limitation, an exemplary process might include a parylene dielectric coating step followed by photolithography patterning of vias and via etching in an oxygen plasma, and thereafter photolithographic masking and deposition of a subsequent electrode and trace layer. Those skilled in the art will understand the obvious alternatives drawn out by the aforementioned exemplary process.
  • [0110]
    Exemplary dimensions of the exemplary sensors (1), (2), (3) include, without limitation a 2 μm spacing between conductive plates having a thickness of approximately 2 μm, with length and widths depending upon the particular capacitive structure fabricated, which also may be said for the exemplary spacing and thickness dimensions recited.
  • [0111]
    Referring to FIGS. 22-24, a second set of exemplary sensors for use with the sensor arrays 20, 36, 52 of the present invention include sealed compartment sensors operative to measure in-vivo compartment pressures. The exemplary sensors comprise piezoelectric cantilevers fabricated from single crystal silicon, with each cantilever including an integrated Wheatstone bridge for automated offset balance. Piezoresistive microcantilevers include piezoresistive materials such as doped silicon that change in resistance according to the amount of strain imparted from the change in crystal structure. Hence, the relationship between the change in resistivity and the change in length (strain) can be characterized and calibrated as a strain sensor.
  • [0112]
    Multiple piezoelectric microcantilevers are mounted onto FR4 epoxy laminate in a predetermined pattern and embedded within an enclosure of epoxy material to form a portion or all of an exemplary array, which in exemplary form includes nine microcantilevers spaced from one another to evenly cover an area of 1 mm×1 mm. Each microcantilever includes a pyramidal tip located at the very end of the cantilever beam with a thickness of approximately 17 μm and dimensions as shown in FIG. 24. An epoxy, such as an FDA approved epoxy, is applied to the pattern of microcantilevers to form a pattern of capsules having a thickness of less than 2 mm. Each microcantilever is connected to an EMD 28, 38, 54 that multiplexes, signal conditions, amplifies and quantizes the signals. Those of ordinary skill will understand that certain tests, such as uniform compression tests, may be necessary to correlate the change in resistance to strain of the exemplary piezoelectric microcantilevers arrays.
  • [0113]
    Referencing FIG. 25, each EMD 28, 38, 54 is designed to compensate and calibrate the imbalance in the Wheatstone bridge circuit due to the possible residual stress resulting from the epoxy encapsulation. A multiplexer 72 receives signals from the sensors of the array 20, 36, 52, where the multiplexed signals are conditioned by a signal conditioner 70, which transmits analog signals to a converter 78, thereby feeding digital signals to a microcontroller 71. The microcontroller 71 sends data signals to the transmitter 82, which ASK modulates the signals and disseminates the data in the form of radio frequency signals at 433.92 MHz. The EMD components are powered by an integral power source such as a battery, but may also be powered by electromagnetic induction or radio frequency (RF) induction. It is to be understood that the exemplary EMD structure of FIG. 25 may be utilized with other exemplary sensors and sensor arrays of the instant invention.
  • [0114]
    An exemplary remote receiver 91 includes a radio frequency receiver 93, a digital signal processor 95, and a display 97 for viewing the information derived from the wirelessly transmitted data. An on-board power supply 99 provides the necessary power to the components of the remote receiver, however, those of ordinary skill will understand that on-board power supplies may be replaced or supplemented by remote power supplies such as by way of power outlets. In exemplary form, the radio frequency signals are converted to electronic signals by the receiver 93 and output to the digital signal processor 95, which converts the signals into digital data that is output in an analog form to be viewed on the display 97, such as a liquid crystal display of a handheld device or computer monitor.
  • [0115]
    Referencing FIGS. 26-28, three exemplary data sets from a sensor array of the present invention are graphically depicted. In exemplary form, the graphical depictions reflect varying amounts of pressure detected by a certain sensor or groups of sensors of an array subsequent to implantation of the prosthesis. An exemplary graphical user interface includes a depiction of a three-dimensional model of the prosthesis (not shown), allowing a user to move a cursor over the model to gain feedback from a particular sensor or group of sensors regarding exerted pressures or a concentration of a particular substance or group of substances. In this manner, a surgeon or attending physician obtains substantially real-time feedback regarding the load distributions on the prosthesis, as well as feedback regarding the onset of infection or an insidious condition such as premature failure or improper biomechanical alignment.
  • [0116]
    Referring to FIGS. 29 and 30, a third set of exemplary sensors for use with the sensor arrays 20, 36, 52 of the present invention include microchannels lined with MEMS microcantilever sensors 174 (resistive, FIG. 29, or capacitive, FIG. 30) to measure fluid properties and contaminations. These sensors are operative to detect certain components, contaminants, and properties relevant to the prosthetic joint and generate detection data representative of the component, contaminant, or property detected. Exemplary microcantilevers may be fabricated consistent with the disclosures of U.S. Pat. Nos. 6,289,717, 5,719,324, and 6,763,705, the disclosures of each of which are hereby incorporated by reference.
  • [0117]
    The following is a nonexhaustive, exemplary listing of the components, contaminants, and properties that may be detected in the synovial fluid that bathes the prosthetic joint. It is to be understood that the exemplary sensors for use with the present invention may detect or measure one or more of the following: viscosity of the synovial fluid; pH of the synovial fluid; cell count within the synovial fluid; protein within the synovial fluid; phospholipids within the synovial fluid; hyaluronic acid within the synovial fluid; leukocytes within the synovial fluid; neutrophils within the synovial fluid; bacterial deoxyribonucleic acid within the synovial fluid; antibodies within the synovial fluid; glucose concentration within the synovial fluid; lactate dehydrogenase (LDH) within the synovial fluid; uric acid crystals within the synovial fluid; MMP-9 antigens (gelatinase-B) within the synovial fluid; nerve growth factor within the synovial fluid; excitatory amino acids (EAA) glutamate and aspartate within the synovial fluid; insulin-like growth factor I (IGF-I) and its binding proteins (IGFBP) 3 and 4 within the synovial fluid; oxidase activity within the synovial fluid; polyamine oxidases within the synovial fluid; caeruloplasmin (Cp) concentration within the synovial fluid; beta-glucuronidase content within the synovial fluid; S100A8/A9 within the synovial fluid; C reactive protein within the synovial fluid; rheumatoid factor within the synovial fluid; C3 and C4 within the synovial fluid; metal particulate within the synovial fluid; polyethylene particulate within the synovial fluid; bone particulate within the synovial fluid; cement particulate within the synovial fluid; osteolytic enzymes within the synovial fluid; genetic markers within the synovial fluid; antibody markers within the synovial fluid; temperature of the synovial fluid; specific gravity of the synovial fluid; and white cells (and differential cell type) within the synovial fluid.
  • [0118]
    Referring to FIGS. 31-34, the third set of exemplary sensors may be incorporated into a dual-layer design adapted to be embedded within one or more of the prosthetic implants 12, 14, 16. In this exemplary dual-layer structure, a first layer is comprised of a sensor layer 170 and a second layer is comprised of an electronics layer 172. The sensor layer 170 includes a plurality of functionalized microcantilevers 174, microfluidic channels 176, and micropumps 178. A small inlet 180 to the microfluidic channel corresponds with an opening through the prosthetic implant 12, 14, 16 (for example, the tibial tray 12) to allow interstitial fluids to contact the sensors 174 of the array. The microfluidic channels 176 are in communication with the micropumps 178, which are operative to pump a fixed volume of interstitial fluid into contact with the microcantilevers 174 to allow generation of chemical analysis data representative of the constituency of the interstitial fluid exposed to the microcantilevers 174. A downstream portion 186 of the microchannel structure 176 combines the individual fluid paths, subsequent to passing beyond the microcantilevers 174, into a single outlet stream that is removed by the action of a second micropump 178. Exemplary micropumps 178 include, without limitation, micropumps transporting fixed volumes of fluid under the influence of an electric field such as those disclosed in U.S. Pat. No. 6,733,244, the disclosure of which is incorporated by reference (see FIG. 33), as well as Alzet microosmotic pumps available from Durect Corporation (www.alzet.com).
  • [0119]
    Referencing FIG. 34, each sensor array 20, 36, 52 is in communication with an EMD (see FIG. 25) to receive deflection signals representative of the deflection of the functionalized microcantilevers 174. An amplifier 190 may interpose the microcantilevers 74 and EMD 28, 38, 54 to amplify the deflection signals of the functionalized microcantilevers 74.
  • [0120]
    A complementary pair of microcantilevers 174 may be utilized, one reference set corresponding to a controlled environment without any bound biochemical agents, while a second signal set, identical to the first set, is exposed to biochemical agents within the interstitial fluid. External vibrations cause both the signal and the reference cantilever set to vibrate and without the reference set, such vibrations might, in severe conditions, overwhelm the minute deflection forces resulting from the binding of biochemical agents to the microcantilevers 174. Subtracting the reference vibrations from the signal vibrations helps reduce this interference.
  • [0121]
    The output signal from each piezoresistive cantilever 174 is measured using an on-chip Wheatstone bridge. One of the cantilevers then acts as a mechanical filter for the noise that both the measuring cantilever and the reference cantilever experience using the following expression: V 0 V bias = 1 4 Δ R R
    The fractional change in resistance (ΔR/R) of a piezoresistive cantilever is described by the following expression: Δ R R = β 3 π L ( 1 - υ ) t ( σ 1 - σ 2 ) Equation ( 1 )
    Where πL is the piezoresistive coefficient of silicon along the axis, σ1 is the longitudinal stress, σ2 is the transverse stress, t is thickness of cantilever, ν is Poisson's ratio, and β is a factor that adjusts for the thickness of the piezoresistor. From Equation (1), the ratio (ΔR/R) is proportional to differential stress (σ1−σ2). Differential stress distribution over a cantilever surface depends on the geometric factors of the layers and the chemo-mechanical forces between the biomolecules and the capture or hybridization layers. Therefore, the deflection signal can be increased by maximizing differential stress (σ1−σ2) by changing the geometric factors.
  • [0122]
    The change in resistance of a piezoresistive cantilever is related to the analyte and receptor concentration by the following expression: Δ σ = ( Δ σ 0 ) [ 1 - - k f C N r t ] Equation ( 2 ) Δ R R = Π [ ( Δ σ 1 ) 0 - ( Δ σ 2 ) 0 ] [ 1 - - k f C N r t ] Equation ( 3 )
      • Where
        • Effective reaction rate Kf=(K−a|u|), u=flow velocity;
        • Π=β*3πL(1−ν)/t is the piezoresistor coefficient,
        • (Δσ1)0=ΔG1N0A−1 mA−1,
        • (Δσ2)0=ΔG2N0A−1 mA−1,
        • ΔG=change in the Gibbs free energy caused by the adsorption process;
        • Nr=Number of available receptors;
        • C∞=analyte concentration;
        • Am=area of receptor coating; and
        • A=number of analyte molecules per mole.
  • [0133]
    Also, the deflection (z) of the tip of an ordinary microcantilever is calculated from using Stoney's Equation: z = 3 2 ( 1 - υ ) Et m 2 Δ σ Equation ( 4 )
    where λ, ν, E, Δσ, and tm are the microcantilever's effective length, Poisson's ratio, Young's modulus, differential surface stress and its thickness. Using Equations (2) and (4), the deflection of the cantilever due to surface stresses is measured.
  • [0134]
    From Equations (2), (3), & (4), it is clear that in order to measure the change in resistance, one needs to know the analyte concentration and the number of available receptors and the flow velocity of the fluid.
  • [0135]
    To achieve this, the micropump is used to generate a predetermined flow. Electro-osmotic flow is particularly suitable for microfluidic channels with diameters of less than 0.1 mm. The phenomenon of electro-osmotic flow and the equation governing the flow transport are discussed below.
  • [0136]
    As the characteristic dimensions of the channels decrease to micro ranges, the fluid flow behaviors are increasingly influenced by interfacial effects such as the electrical double layer (EDL). Because of the EDL influence, the microchannel flows deviate from predications of the traditional Navier-Stokes equations. The large surface-area-to-volume ratio in the microchannel causes the excess shear stress effect of the flow.
  • [0137]
    For example, consider a microchannel located between two parallel plates with its coordinate system shown in the following depiction:
    To consider EDL and electrostatic field effects on fluid flow through the microchannel, the distribution of electrical potential and net charge density between the two plates must be evaluated. Consider a liquid phase containing positive and negative ions in contact with a planar negatively charged surface. An EDL field will be established. According to the theory of electrostatics, the relationship between the electrical potential and the net charge density per unit volume ρe at any point in the solution is described by the two-dimensional Poisson equation 2 ψ x 2 + 2 ψ y 2 = - ρ e ɛɛ 0 , Equation 5
    Where ρe is the charge density, ε is the dielectric constant of the medium, and ε0 is permittivity of vacuum. For any fluid consisting of two kinds of ions of equal and opposite charge (Z+ and Z), the number of ions of each type is given by the Boltzmann equation
    n =n 0 e zeψ/k b bT , n + =n 0 e −zeψ/k b T,   Equation 6
    where n+ and n are the concentrations of the positive and negative ions, n0 is bulk concentration of ions, ezeψ/k b T is the Boltzmann factor, kb is the Boltzmann constant,
    and T is the absolute temperature. The local net charge density in a unit volume of the fluid is given by
    ρe=(n + −n )ze=−2n 0 ve sin h(zeψ/k b T).   Equation 7
    Substituting Equation 7 into Equation 5, we obtain a nonlinear two dimensional Poisson-Boltzmann equation, 2 ψ x 2 + 2 ψ y 2 = 2 nze ɛɛ 0 sinh ( ze ψ / k b T ) .
  • [0138]
    Microchannel flow is changed by the presence of an electrostatic potential field. For the current study of electro-osmotic flow, it is assumed that the applied electrostatic potential is much larger than the streaming potential induced by the current due to transport of charges by the liquid flow. Therefore, we obtain the distribution of the electrostatic field by solving the Laplace equation: 2 ϕ x 2 + 2 ϕ y 2 = 0.
  • [0139]
    The Navier-Stokes equations mathematically represent the fluid flow in general cases. However, they have to be modified for the case of microchannel flow to include the electrical force generated by the interaction between EDL and the electrical potential field. The equations of motion for an incompressible liquid are given by · u _ = 0 u _ t + u _ · u _ = - 1 ρ f p + μ ρ f 2 u _ - ρ e ρ f ( ( ψ + ϕ ) )
    In this equation, u is the velocity vector containing u and v components along the x and y directions, ρf and μ are the density and dynamic viscosity of the liquid, respectively, and ρe is the charge density.
  • [0140]
    The channel length is assumed to be long enough that the flow is fully developed at the outflow boundary. Initially, liquid fluid is fills the channel and the flow is stationary. An equilibrium electrical double layer is formed near wall boundaries. Once the driving force (the static electrical potential at the inlet) is activated, the flow starts to move. No slip velocity boundary conditions are used at the walls. At the flow inlet, the zero velocity gradient is assumed because the mass flow rate is determined by the activated electrical potential.
  • [0141]
    The boundary conditions applied for this case are: X = 0 u x = 0 , υ x = 0 , p x = 0 , ψ x = 0 , ϕ = C 1 X = L u x = 0 , υ x = 0 , p ( L , y ) = 0 y Gx · sinh ψ ψ y y , ψ x = 0 , ϕ = C 2 Y = 0 u = 0 , υ = 0 , p y = 1 Re 2 υ y 2 + Gx · sinh ψ ψ y , ψ = C 3 , ϕ y = 0 Y = W u = 0 , υ = 0 , p y = 1 Re 2 υ y 2 + Gx · sinh ψ ψ y , ψ = C 4 , ϕ v = 0 ,
    where C1, C2, C3, and C4 are known constants.
  • [0142]
    The micropump transports fluid onto the sensor array through a parallel microchannel structure as shown in FIG. 34. The functionalized microcantilevers within the microconduits are deflected by predetermined compositions, thereby operating to provide a predetermined chemical analysis of the fluid.
  • [0143]
    The design of the force-sensing prosthetic joint components using wireless sensor and telemetry technology is a major advancement for the orthopaedic and CAOS industries. An exemplary sensor array includes numerous sensors oriented in a triangular fashion to measure lateral and medial condylar reaction forces, total reaction forces, and the difference in reaction forces between medial and lateral aspects of the permanent or trial prosthetic component. The sensors include a capacitive readout and power for the telemetry is provided inductively. The power can be supplied either by a coil worn near the knee during testing or a small rechargeable battery is incorporated into this system so that the rechargeable battery is charged inductively prior to testing. Alternatively, a piezoelectric sensor providing an output charge may be utilized to power the system dependent upon the dynamic load available to the sensor. This charge in certain instances is sufficient power the telemetry system and recharge any electrical components used for the telemetry system.
  • [0144]
    The present invention may be utilized to correct ligament balancing in the knee joint during the time of surgery utilizing readings gathered from trial and permanent prosthetic components. In addition, utilizing the present invention to measure the loads, to measure the symmetry of the loads at the femorotibial interface in a knee replacement, and to measure the composition of the synovial fluid intra-operatively allows a physician to greatly enhance ligament balancing and inhibiting premature wear of the prosthetic. The present invention may also be utilized to detect bearing surface forces that, in turn, may be used to determine active muscle forces, such as the quadriceps muscle, and/or resistive force, such as ligament forces that provide constraint to the knee joint.
  • [0145]
    For example, if abnormal polyethylene levels are detected and the loading conditions within the joint are known it might be possible to correct the imbalances and reverse or decrease wear. If metal debris is detected, wear-through of the insert or excessive corrosion or wear from the Morse taper junctions in modular implants is detected, an appropriate intervention may be performed.
  • [0146]
    It is also within the scope of the invention that the sensors and control electronics be incorporated into other prosthetic components including, without limitation, femoral cup prostheses, femoral cup insert prosthesis, femoral stem prosthesis, and other joint replacement components. Those of ordinary skill will readily understand how to adapt the exemplary teachings recited herein to fabricate and use variations such as those discussed above. Moreover, the exemplary teachings of the instant invention are likewise applicable to prosthetic trail components in order to at least sense pressure to facilitate proper biomechanical operation of the prosthetic joint once implanted. Moreover the exemplary teachings are applicable to fixed bearing and mobile bearing prosthetic implants.
  • [0147]
    It is also within the scope of the invention that the microsensors and control electronics are incorporated into prosthetic braces to gauge pressures exerted against the brace as a manner to evaluate the effectiveness of the brace and whether the mammalian body part being braced is becoming stronger and/or whether the force distribution against he brace is within predetermined tolerances, tending to show proper biomechanical function.
  • [0148]
    It is further within the scope of the instant invention that the sensors and control electronics are responsive in nature in order to automatically prompt the recipient of the prosthesis that one or more monitored conditions is outside of the predetermined range, thereby requiring consultation with the surgeon or attending physician. By way of example, and not limitation, the prosthetic joint may incorporate a wobble insert that would be activated and thereby vibrate when one of more monitored conditions is outside of the normal parameters. Other exemplary methods of actively communicating with the recipient include direct communication to a remove device 91 given to the recipient that would self-diagnose the condition and request the patient to consult the surgeon or attending physician.
  • [0149]
    For purposes of the instant invention, microchannel includes those conduits having diameters or restrictive dimensions of 0.1 mm or less, and microsensors include those sensors having dominant dimensions generally less than 1000 μm, and certainly those having dominant dimensions less than 100 μm.
  • [0150]
    Following from the above description and invention summaries, it should be apparent to those of ordinary skill in the art that, while the subject matter described herein constitutes exemplary teachings of the present invention, the invention contained herein is not limited to these precise teachings and changes may be made to the aforementioned teachings without departing from the scope of the invention as defined by the claims. Additionally, it is to be understood that the invention is defined by the claims and it is not intended that any limitations or elements describing the exemplary embodiments set forth herein are to be incorporated into the interpretation of any claim element unless such limitation or element is explicitly stated. Likewise, it is to be understood that it is not necessary to meet any or all of the identified advantages or objects of the invention disclosed herein in order to fall within the scope of any one of the claims, since the invention is defined by the claims and since inherent and/or unforeseen advantages of the present invention may exist even though they may not have been explicitly discussed herein.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3915015 *Mar 18, 1974Oct 28, 1975Stanford Research InstStrain gauge transducer system
US4501266 *Mar 4, 1983Feb 26, 1985Biomet, Inc.Knee distraction device
US4503705 *Mar 14, 1983Mar 12, 1985The Langer Biomechanics Group, Inc.Flexible force sensor
US4822362 *May 19, 1987Apr 18, 1989Walker Peter SProcess and apparatus for tibial plateau compenent
US4997445 *Dec 8, 1989Mar 5, 1991Zimmer, Inc.Metal-backed prosthetic implant with enhanced bonding of polyethylene portion to metal base
US5085252 *Aug 29, 1990Feb 4, 1992North Carolina State UniversityMethod of forming variable cross-sectional shaped three-dimensional fabrics
US5197488 *Apr 5, 1991Mar 30, 1993N. K. Biotechnical Engineering Co.Knee joint load measuring instrument and joint prosthesis
US5326363 *Sep 14, 1992Jul 5, 1994Zimmer, Inc.Provisional implant
US5360016 *Mar 22, 1993Nov 1, 1994N. K. Biotechnical Engineering CompanyForce transducer for a joint prosthesis
US5412619 *Apr 14, 1994May 2, 1995Bauer; WillThree-dimensional displacement of a body with computer interface
US5425775 *Nov 2, 1993Jun 20, 1995N.K. Biotechnical Engineering CompanyMethod for measuring patellofemoral forces
US5456724 *Dec 15, 1993Oct 10, 1995Industrial Technology Research InstituteLoad sensor for bone graft
US5465760 *Oct 25, 1993Nov 14, 1995North Carolina State UniversityMulti-layer three-dimensional fabric and method for producing
US5470354 *Aug 10, 1994Nov 28, 1995Biomet Inc.Force sensing apparatus and method for orthopaedic joint reconstruction
US5518008 *Aug 25, 1994May 21, 1996Spectral Sciences Research CorporationStructural analyzer, in particular for medical implants
US5529070 *Sep 27, 1994Jun 25, 1996Advanced Technology Laboratories, Inc.Acquisition and display of ultrasonic images from sequentially oriented image planes
US5645077 *Jun 16, 1994Jul 8, 1997Massachusetts Institute Of TechnologyInertial orientation tracker apparatus having automatic drift compensation for tracking human head and other similarly sized body
US5656785 *Aug 7, 1995Aug 12, 1997The Charles Stark Draper Laboratory, Inc.Micromechanical contact load force sensor for sensing magnitude and distribution of loads and tool employing micromechanical contact load force sensor
US5669914 *Feb 16, 1996Sep 23, 1997Board Of Regents Of The University Of ColoradoRotation alignment instrument
US5678448 *Jan 14, 1994Oct 21, 1997Fullen Systems, Inc.System for continuously measuring forces applied by the foot
US5719324 *Jun 16, 1995Feb 17, 1998Lockheed Martin Energy Systems, Inc.Microcantilever sensor
US5733292 *Sep 15, 1995Mar 31, 1998Midwest Orthopaedic Research FoundationArthroplasty trial prosthesis alignment devices and associated methods
US5777467 *Jan 24, 1996Jul 7, 1998Microstrain, Inc.Miniaturized displacement transducer assembly
US5807284 *Jun 25, 1997Sep 15, 1998Massachusetts Institute Of TechnologyInertial orientation tracker apparatus method having automatic drift compensation for tracking human head and other similarly sized body
US5840047 *Apr 16, 1996Nov 24, 1998Prosthetic Sensing Technologies, LlcSensor device for monitoring a prosthetic device
US5876325 *Sep 30, 1997Mar 2, 1999Olympus Optical Co., Ltd.Surgical manipulation system
US5879398 *Feb 14, 1995Mar 9, 1999Zimmer, Inc.Acetabular cup
US5941904 *Sep 12, 1997Aug 24, 1999Sulzer Intermedics Inc.Electromagnetic acceleration transducer for implantable medical device
US6034296 *Dec 4, 1997Mar 7, 2000Elvin; NiellImplantable bone strain telemetry sensing system and method
US6073484 *Jul 19, 1996Jun 13, 2000Cornell Research Foundation, Inc.Microfabricated torsional cantilevers for sensitive force detection
US6122538 *Jan 16, 1997Sep 19, 2000Acuson CorporationMotion--Monitoring method and system for medical devices
US6122541 *Dec 10, 1996Sep 19, 2000Radionics, Inc.Head band for frameless stereotactic registration
US6129122 *Jun 16, 1999Oct 10, 20003Tex, Inc.Multiaxial three-dimensional (3-D) circular woven fabric
US6143035 *Jan 28, 1999Nov 7, 2000Depuy Orthopaedics, Inc.Implanted bone stimulator and prosthesis system and method of enhancing bone growth
US6245109 *Jun 2, 2000Jun 12, 2001Intellijoint Systems, Ltd.Artificial joint system and method utilizing same for monitoring wear and displacement of artificial joint members
US6312393 *Feb 29, 2000Nov 6, 2001Marcio Marc A. M. AbreuContact device for placement in direct apposition to the conjunctive of the eye
US6523391 *Jun 8, 2001Feb 25, 2003Variform Inc.Vertical height impact testing apparatus
US6553681 *Apr 30, 2002Apr 29, 2003Carl Roger Ekholm, Jr.Methods for measuring a bio-material for use in an implant
US6573706 *Jan 31, 2001Jun 3, 2003Intellijoint Systems Ltd.Method and apparatus for distance based detection of wear and the like in joints
US6583630 *Jan 31, 2001Jun 24, 2003Intellijoint Systems Ltd.Systems and methods for monitoring wear and/or displacement of artificial joint members, vertebrae, segments of fractured bones and dental implants
US6610096 *Aug 22, 2001Aug 26, 2003Macdonald Stuart G.Prosthetic implants having enhanced utility
US6657703 *May 17, 2001Dec 2, 2003Canon Kabushiki KaishaExposure apparatus, maintenance method therefor, semiconductor device manufacturing method, and semiconductor manufacturing factory
US6706005 *Aug 24, 2001Mar 16, 2004The Cleveland Clinic FoundationApparatus and method for assessing loads on adjacent bones
US7097662 *Aug 25, 2004Aug 29, 2006Ut-Battelle, LlcIn-vivo orthopedic implant diagnostic device for sensing load, wear, and infection
US7195645 *Jul 9, 2004Mar 27, 2007Depuy Products, Inc.In vivo joint space measurement device and method
US20010012932 *Apr 16, 2001Aug 9, 2001Ferdinand PeerInstrument for compensating for hand tremor during the manipulation of fine structures
US20020102743 *Feb 13, 2002Aug 1, 2002The Regents Of The University Of CaliforniaApparatus and method for visually identifying micro-forces with a palette of cantilever array blocks
US20020104376 *Feb 7, 2001Aug 8, 2002Steven DanylukIonization contact potential difference gyroscope
US20020130673 *Dec 6, 2001Sep 19, 2002Sri InternationalElectroactive polymer sensors
US20020180306 *Jan 18, 2002Dec 5, 2002Hunt Brian D.Carbon nanobimorph actuator and sensor
US20030003135 *Jun 28, 2001Jan 2, 2003Leung Jeffrey C.Article for drug delivery and methods of making and using same
US20030026758 *Jul 26, 2002Feb 6, 2003Baker Gregg S.Method and device for monitoring real-time position of an area targeted by a radiosurgery system
US20030069591 *Aug 27, 2002Apr 10, 2003Carson Christopher PatrickComputer assisted knee arthroplasty instrumentation, systems, and processes
US20030069644 *Oct 5, 2001Apr 10, 2003Nebojsa KovacevicDual-tray teletibial implant
US20030114735 *Aug 9, 2002Jun 19, 2003Silver James H.Implantable, retrievable sensors and immunosensors
US20030119398 *Nov 29, 2002Jun 26, 2003Alex Bogdanovich3-D resin transfer medium and method of use
US20040019384 *Mar 21, 2003Jan 29, 2004Bryan KirkingImplantable prosthesis for measuring six force components
US20040064191 *Sep 22, 2003Apr 1, 2004Wasielewski Ray C.Apparatus, system and method for intraoperative performance analysis during joint arthroplasty
US20040080319 *Oct 23, 2003Apr 29, 2004Merrill John H.MIP microcantilever sensor and a method of using thereof
US20040097952 *Nov 6, 2003May 20, 2004Sarin Vineet KumarNon-image, computer assisted navigation system for joint replacement surgery with modular implant system
US20040152970 *Jan 30, 2003Aug 5, 2004Mark HunterSix degree of freedom alignment display for medical procedures
US20040243148 *Apr 8, 2004Dec 2, 2004Wasielewski Ray C.Use of micro- and miniature position sensing devices for use in TKA and THA
US20050010302 *Mar 31, 2004Jan 13, 2005Terry DietzTelemetric tibial tray
US20050068044 *Oct 24, 2002Mar 31, 2005William PeineArray sensor electronics
US20050116673 *Apr 16, 2004Jun 2, 2005Rensselaer Polytechnic InstituteMethods and systems for controlling the operation of a tool
US20050131390 *Apr 25, 2003Jun 16, 2005Russell HeinrichSurgical instruments including mems devices
US20050146076 *Nov 19, 2003Jul 7, 2005Bogdanovich Alexander3-D fabrics and fabric preforms for composites having integrated systems, devices, and/or networks
US20050165317 *Aug 13, 2004Jul 28, 2005Turner Nicholas M.Medical devices
US20050171456 *Jan 29, 2004Aug 4, 2005Hirschman Gordon B.Foot pressure and shear data visualization system
US20050186081 *Feb 24, 2004Aug 25, 2005Mohamed Mansour H.Wind blade spar cap and method of making
US20050234555 *Apr 16, 2004Oct 20, 2005Depuy Spine, Inc.Intervertebral disc with monitoring and adjusting capabilities
US20050245820 *Apr 28, 2004Nov 3, 2005Sarin Vineet KMethod and apparatus for verifying and correcting tracking of an anatomical structure during surgery
US20050273170 *Jun 8, 2004Dec 8, 2005Navarro Richard RProsthetic intervertebral spinal disc with integral microprocessor
US20060004431 *Jun 30, 2005Jan 5, 2006Fuller Thomas AProphylactic bactericidal implant
US20060047283 *Aug 25, 2004Mar 2, 2006Evans Boyd M IiiIn-vivo orthopedic implant diagnostic device for sensing load, wear, and infection
US20060058604 *Aug 25, 2004Mar 16, 2006General Electric CompanySystem and method for hybrid tracking in surgical navigation
US20060075816 *Nov 21, 2003Apr 13, 2006Koninklijke Philips Electronics, N.V.Activity monitoring
US20060142657 *Feb 21, 2006Jun 29, 2006Mako Surgical CorporationHaptic guidance system and method
US20060150734 *Nov 21, 2003Jul 13, 2006Koninklijke Philips Electronics N.V.Activity monitoring
US20060235314 *Jan 30, 2004Oct 19, 2006Michele MigliuoloMedical and surgical devices with an integrated sensor
US20060254369 *May 10, 2006Nov 16, 2006Euisik YoonFlexible modular sensor systems
US20060271199 *May 17, 2006Nov 30, 2006Johnson Lanny LNavigational markers in implants
US20060282168 *Jun 13, 2005Dec 14, 2006Sherman Jason TOrthopaedic prosthesis having a superparamagnetic material and associated method
US20070032748 *Jul 28, 2005Feb 8, 2007608442 Bc Ltd.System for detecting and analyzing body motion
US20070065077 *Sep 26, 2006Mar 22, 2007Luna Innovations IncorporatedFiber Optic Position and Shape Sensing Device and Method Relating Thereto
US20070189902 *Sep 18, 2006Aug 16, 2007Mohamed Mansour HWind blade spar cap and method of making
US20070219641 *Mar 19, 2007Sep 20, 2007Zimmer Technology, Inc.Prosthetic hip implants
US20070225731 *Mar 21, 2007Sep 27, 2007Pierre CoutureMethod and system for tracking tools in computer-assisted surgery
US20070233258 *Feb 28, 2006Oct 4, 2007Zimmer Spine, Inc.Vertebroplasty- device and method
US20070270686 *May 3, 2007Nov 22, 2007Ritter Rogers CApparatus and methods for using inertial sensing to navigate a medical device
US20070287911 *Jun 1, 2007Dec 13, 2007Fraunhofer-Gesellschaft Zur Forderung Der AngewandtenMethod and device for navigating and positioning an object relative to a patient
US20080010705 *May 18, 2007Jan 10, 2008Mako Surgical Corp.Method and apparatus for controlling a haptic device
US20080010706 *May 18, 2007Jan 10, 2008Mako Surgical Corp.Method and apparatus for controlling a haptic device
US20080039868 *Jun 28, 2007Feb 14, 2008Aesculap Ag & Co. KgCalibration method and calibration device for a surgical referencing unit
US20080064947 *Mar 8, 2007Mar 13, 2008Medtronic, Inc.Method And Apparatus To Optimize Electrode Placement For Neurological Stimulation
US20080081982 *Mar 8, 2007Apr 3, 2008Medtronic, Inc.Method And Apparatus For Optimizing A Computer Assisted Surgical Procedure
US20080097187 *Oct 20, 2006Apr 24, 2008Medtronic, Inc.System for navigating a planned procedure within a body
US20080123921 *Oct 20, 2006May 29, 2008Medtronic, Inc.System for identification of anatomical landmarks
US20080130965 *Nov 23, 2004Jun 5, 2008Avinash Gopal BMethod and apparatus for parameter assisted image-guided surgery (PAIGS)
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7849751 *Dec 14, 2010Clemson University Research FoundationContact sensors and methods for making same
US8015024Sep 6, 2011Depuy Products, Inc.System and method for managing patient-related data
US8029566Jun 2, 2008Oct 4, 2011Zimmer, Inc.Implant sensors
US8070752Jan 9, 2008Dec 6, 2011Biomet Manufacturing Corp.Patient specific alignment guide and inter-operative adjustment
US8075627 *Dec 13, 2011Depuy Products, Inc.System and method for transmitting orthopaedic implant data
US8080064Dec 20, 2011Depuy Products, Inc.Tibial tray assembly having a wireless communication device
US8092412May 27, 2010Jan 10, 2012Depuy Products, Inc.Apparatus, system, and method for transcutaneously transferring energy
US8092465Jan 10, 2012Biomet Manufacturing Corp.Patient specific knee alignment guide and associated method
US8127623Oct 6, 2008Mar 6, 2012Pressure Profile Systems Inc.Capacitive tactile tile sensor
US8133234Feb 20, 2009Mar 13, 2012Biomet Manufacturing Corp.Patient specific acetabular guide and method
US8170641May 1, 2012Biomet Manufacturing Corp.Method of imaging an extremity of a patient
US8187213May 29, 2012Depuy Products, Inc.Apparatus, system, and method for transcutaneously transferring energy
US8241293Feb 26, 2010Aug 14, 2012Biomet Manufacturing Corp.Patient specific high tibia osteotomy
US8241296Dec 23, 2008Aug 14, 2012Zimmer, Inc.Use of micro and miniature position sensing devices for use in TKA and THA
US8244368Aug 27, 2008Aug 14, 2012Depuy Products, Inc.Apparatus, system, and method for transcutaneously transferring energy
US8282646Oct 9, 2012Biomet Manufacturing Corp.Patient specific knee alignment guide and associated method
US8298237Oct 30, 2012Biomet Manufacturing Corp.Patient-specific alignment guide for multiple incisions
US8377066Feb 19, 2013Biomet Manufacturing Corp.Patient-specific elbow guides and associated methods
US8398646Mar 19, 2013Biomet Manufacturing Corp.Patient-specific knee alignment guide and associated method
US8407067Aug 31, 2010Mar 26, 2013Biomet Manufacturing Corp.Method and apparatus for manufacturing an implant
US8421072 *Nov 12, 2008Apr 16, 2013Alcatel LucentElectronic device having thermally managed electron path and method of thermal management of very cold electrons
US8473305Jun 12, 2009Jun 25, 2013Biomet Manufacturing Corp.Method and apparatus for manufacturing an implant
US8486150Apr 7, 2011Jul 16, 2013Biomet Manufacturing Corp.Patient-modified implant
US8532807Jun 6, 2011Sep 10, 2013Biomet Manufacturing, LlcPre-operative planning and manufacturing method for orthopedic procedure
US8535387Mar 7, 2011Sep 17, 2013Biomet Manufacturing, LlcPatient-specific tools and implants
US8568487Dec 23, 2010Oct 29, 2013Biomet Manufacturing, LlcPatient-specific hip joint devices
US8591516Nov 29, 2010Nov 26, 2013Biomet Manufacturing, LlcPatient-specific orthopedic instruments
US8597365Aug 4, 2011Dec 3, 2013Biomet Manufacturing, LlcPatient-specific pelvic implants for acetabular reconstruction
US8603180May 19, 2011Dec 10, 2013Biomet Manufacturing, LlcPatient-specific acetabular alignment guides
US8608748Sep 16, 2008Dec 17, 2013Biomet Manufacturing, LlcPatient specific guides
US8608749Mar 7, 2011Dec 17, 2013Biomet Manufacturing, LlcPatient-specific acetabular guides and associated instruments
US8614108Jan 10, 2013Dec 24, 2013Alcatel LucentElectronic device having thermally managed electron path and method of thermal management of very cold electrons
US8632464Sep 11, 2006Jan 21, 2014DePuy Synthes Products, LLCSystem and method for monitoring orthopaedic implant data
US8632547May 12, 2011Jan 21, 2014Biomet Sports Medicine, LlcPatient-specific osteotomy devices and methods
US8668700Apr 29, 2011Mar 11, 2014Biomet Manufacturing, LlcPatient-specific convertible guides
US8668742Nov 30, 2011Mar 11, 2014DePuy Synthes Products, LLCSystem and method for transmitting orthopaedic implant data
US8715289Apr 15, 2011May 6, 2014Biomet Manufacturing, LlcPatient-specific numerically controlled instrument
US8764760Jul 1, 2011Jul 1, 2014Biomet Manufacturing, LlcPatient-specific bone-cutting guidance instruments and methods
US8820173Mar 8, 2010Sep 2, 2014Andrew C. ClarkContact sensors and methods for making same
US8828087Aug 13, 2012Sep 9, 2014Biomet Manufacturing, LlcPatient-specific high tibia osteotomy
US8858561Jun 18, 2009Oct 14, 2014Blomet Manufacturing, LLCPatient-specific alignment guide
US8864769Mar 7, 2011Oct 21, 2014Biomet Manufacturing, LlcAlignment guides with patient-specific anchoring elements
US8875714Feb 22, 2007Nov 4, 2014The Invention Science Fund I, LlcCoded-sequence activation of surgical implants
US8900244Jan 5, 2012Dec 2, 2014Biomet Manufacturing, LlcPatient-specific acetabular guide and method
US8903530Sep 6, 2013Dec 2, 2014Biomet Manufacturing, LlcPre-operative planning and manufacturing method for orthopedic procedure
US8956364Aug 29, 2012Feb 17, 2015Biomet Manufacturing, LlcPatient-specific partial knee guides and other instruments
US8979936Jun 21, 2013Mar 17, 2015Biomet Manufacturing, LlcPatient-modified implant
US9005297Jan 17, 2013Apr 14, 2015Biomet Manufacturing, LlcPatient-specific elbow guides and associated methods
US9060788Dec 11, 2012Jun 23, 2015Biomet Manufacturing, LlcPatient-specific acetabular guide for anterior approach
US9066727Mar 3, 2011Jun 30, 2015Materialise NvPatient-specific computed tomography guides
US9066734Aug 31, 2011Jun 30, 2015Biomet Manufacturing, LlcPatient-specific sacroiliac guides and associated methods
US9084618Jun 11, 2012Jul 21, 2015Biomet Manufacturing, LlcDrill guides for confirming alignment of patient-specific alignment guides
US9095275 *Jun 3, 2010Aug 4, 2015Andrew C. ClarkContact sensors and methods for making same
US9095436 *Apr 14, 2009Aug 4, 2015The Invention Science Fund I, LlcAdjustable orthopedic implant and method for treating an orthopedic condition in a subject
US9095437Aug 21, 2009Aug 4, 2015The Invention Science Fund I, LlcAdjustable orthopedic implant and method for treating an orthopedic condition in a subject
US9113971Sep 29, 2010Aug 25, 2015Biomet Manufacturing, LlcFemoral acetabular impingement guide
US9173661Oct 1, 2009Nov 3, 2015Biomet Manufacturing, LlcPatient specific alignment guide with cutting surface and laser indicator
US9173666Jun 27, 2014Nov 3, 2015Biomet Manufacturing, LlcPatient-specific-bone-cutting guidance instruments and methods
US9204977Mar 8, 2013Dec 8, 2015Biomet Manufacturing, LlcPatient-specific acetabular guide for anterior approach
US9228929 *Oct 23, 2012Jan 5, 2016Xi'an Jiaotong UniversityMethod of on-line rapid fluid density measurement using a piezoresistive micro-cantilever
US9237950Jan 31, 2013Jan 19, 2016Biomet Manufacturing, LlcImplant with patient-specific porous structure
US9241745Dec 13, 2012Jan 26, 2016Biomet Manufacturing, LlcPatient-specific femoral version guide
US9271744Apr 18, 2011Mar 1, 2016Biomet Manufacturing, LlcPatient-specific guide for partial acetabular socket replacement
US9289253Nov 3, 2010Mar 22, 2016Biomet Manufacturing, LlcPatient-specific shoulder guide
US9295497Dec 18, 2012Mar 29, 2016Biomet Manufacturing, LlcPatient-specific sacroiliac and pedicle guides
US9301812Oct 17, 2012Apr 5, 2016Biomet Manufacturing, LlcMethods for patient-specific shoulder arthroplasty
US20060184067 *Feb 15, 2005Aug 17, 2006Clemson UniversityContact sensors and methods for making same
US20070239282 *Apr 7, 2006Oct 11, 2007Caylor Edward J IiiSystem and method for transmitting orthopaedic implant data
US20080208010 *Feb 22, 2007Aug 28, 2008Searete Llc, A Limited Liability Corporation Of The State Of DelawareCoded-sequence activation of surgical implants
US20090005708 *Jun 30, 2008Jan 1, 2009Johanson Norman AOrthopaedic Implant Load Sensor And Method Of Interpreting The Same
US20090033341 *Oct 6, 2008Feb 5, 2009Pressure Profile Systems, Inc.Capacitive tactile tile sensor
US20100118915 *Nov 12, 2008May 13, 2010Alcatel-Lucent Usa Inc.Electronic device having thermally managed electron path and method of thermal management of very cold electrons
US20100249533 *Sep 30, 2010Jay PierceSystem and method for an orthopedic data repository and registry
US20100262160 *Oct 14, 2010Searete Llc, A Limited Liability Corporation Of The State Of DelawareAdjustable orthopedic implant and method for treating an orthopedic condition in a subject
US20100262239 *Oct 14, 2010Searete Llc, A Limited Liability Corporation Of The State DelawareAdjustable orthopedic implant and method for treating an orthopedic condition in a subject
US20120123716 *Jun 3, 2010May 17, 2012Clark Andrew CContact sensors and methods for making same
US20120253345 *Oct 6, 2010Oct 4, 2012University Of MassachusettsDevice and method to measure bone healing
US20130187476 *Mar 8, 2013Jul 25, 2013Fu Da Tong Technology Co., Ltd.Inductive power supply system and intruding metal detection method thereof
US20130261995 *Oct 23, 2012Oct 3, 2013Xi'an Jiaotong UniversityMethod of on-line rapid fluid density measurement using a piezoresistive micro-cantilever
US20140066812 *Aug 15, 2013Mar 6, 2014Institute of Orthopedic Research and EductionSystem and Method for Monitoring the Health of Joints
US20140135655 *Jan 13, 2014May 15, 2014Orthsosensor Inc.Prosthetic Component Having A Compliant Surface
US20140379090 *Aug 8, 2012Dec 25, 2014Ecole Polytechnique Federale De Lausanne (Epfl)In-vivo condition monitoring of metallic implants by electrochemical techniques
US20150126893 *Nov 1, 2013May 7, 2015Maryrose Cusimano ReastonMethod For Determining If Surgically-Implanted Hardware Should Be Removed
WO2011107247A1 *Feb 28, 2011Sep 9, 2011Albert-Ludwigs-Universität FreiburgImplantable device for detecting a vessel wall expansion
WO2014028742A1 *Aug 15, 2013Feb 20, 2014University Of HoustonSystem and method for monitoring the health of joints
Classifications
U.S. Classification623/18.11, 623/11.11, 600/301
International ClassificationA61F2/30, A61B5/00, A61F2/02
Cooperative ClassificationA61B5/4528, A61B5/4851, A61F2002/30878, A61L27/50, A61B5/742, A61F2250/0002, A61F2002/488, A61F2/4657, A61B5/03, A61F2002/4632, A61F2/38, A61B5/14507, A61F2230/0015, A61F2002/4666, A61B2562/028, A61F2/3859, G06F19/3418, A61B5/01, A61B5/14539, A61B5/145, A61B5/076, A61F2002/3067, A61F2002/30673, A61B5/0002, G06F19/327, A61B5/14532, A61F2002/30133, A61F2/389, A61F2/4684
European ClassificationA61B5/45K, G06F19/34C, G06F19/32G, A61L27/50, A61F2/46T, A61F2/38, A61B5/07D, A61B5/03
Legal Events
DateCodeEventDescription
Aug 18, 2008ASAssignment
Owner name: ZIMMER, INC., INDIANA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WASIELEWSKI, RAY C.;REEL/FRAME:021404/0498
Effective date: 20061219